04-007-01 | Zwolle Risk Score (ZRS) | De Luca | 2004 | Coronary Artery Disease (CAD) | Mortality | 5 |
10-037-01 | Zwangerschap bij Aangeboren HARtAfwijkingen I (ZAHARA) | Drenthen | 2010 | Pregnancy | Procedural Complications | 3 |
11-036-01 | Zittermann 2011 | Zittermann | 2011 | Chronic Heart Failure (CHF) | Composite | 0 |
13-082-01 | Zheng 2013 | Zheng | 2013 | Valve Disease | Mortality | 0 |
13-021-02 | Zhang 2013 - Death or First Hospitalization for HF | Zhang | 2013 | Chronic Heart Failure (CHF) | Composite | 0 |
13-021-01 | Zhang 2013 - All-Cause Mortality | Zhang | 2013 | Chronic Heart Failure (CHF) | Mortality | 0 |
13-039-01 | Zhang 2013 | Zhang | 2013 | Coronary Artery Disease (CAD) | MACE | 0 |
11-021-01 | Zhang 2011 | Zhang | 2011 | Population Sample | Mortality | 0 |
07-011-01 | Zhang 2007 | Zhang | 2007 | Coronary Artery Disease (CAD) | Cardiogenic Shock | 1 |
05-018-02 | Zhang 2005 - Ischemic Stroke | Zhang | 2005 | Population Sample | Stroke | 0 |
05-018-03 | Zhang 2005 - Hemorrhagic Stroke | Zhang | 2005 | Population Sample | Stroke | 0 |
05-018-01 | Zhang 2005 - CHD | Zhang | 2005 | Population Sample | MACCE | 0 |
10-024-02 | Zgibor 2010 - Women | Zgibor | 2010 | Population Sample | MACE | 1 |
10-024-01 | Zgibor 2010 - Men | Zgibor | 2010 | Population Sample | MACE | 1 |
11-027-01 | Zethelius 2011 | Zethelius | 2011 | Population Sample | MACCE | 1 |
02-010-01 | Zaroff 2002 | Zaroff | 2002 | Coronary Artery Disease (CAD) | Mortality | 0 |
07-025-01 | Zaliunas 2007 | Zaliunas | 2007 | Coronary Artery Disease (CAD) | Mortality | 0 |
05-020-01 | Zaliunas 2005 | Zaliunas | 2005 | Chronic Heart Failure (CHF) | Mortality | 0 |
13-050-02 | Zakai 2013 - Model 2 | Zakai | 2013 | Population Sample | Venous Thromboembolism (VTE) | 0 |
13-050-01 | Zakai 2013 - Model 1 | Zakai | 2013 | Population Sample | Venous Thromboembolism (VTE) | 0 |
12-033-04 | Zahuranec 2012 - Ischemic or ICH, Model 4 | Zahuranec | 2012 | Stroke | Mortality | 0 |
12-033-03 | Zahuranec 2012 - Ischemic or ICH, Model 3 | Zahuranec | 2012 | Stroke | Mortality | 0 |
12-033-02 | Zahuranec 2012 - Ischemic or ICH, Model 2 | Zahuranec | 2012 | Stroke | Mortality | 0 |
12-033-01 | Zahuranec 2012 - Ischemic or ICH, Model 1 | Zahuranec | 2012 | Stroke | Mortality | 0 |
12-033-08 | Zahuranec 2012 - ICH Only, Model 4 | Zahuranec | 2012 | Stroke | Mortality | 0 |
12-033-07 | Zahuranec 2012 - ICH Only, Model 3 | Zahuranec | 2012 | Stroke | Mortality | 0 |
12-033-06 | Zahuranec 2012 - ICH Only, Model 2 | Zahuranec | 2012 | Stroke | Mortality | 0 |
12-033-05 | Zahuranec 2012 - ICH Only, Model 1 | Zahuranec | 2012 | Stroke | Mortality | 0 |
12-041-01 | Zafrir 2012 | Zafrir | 2012 | Chronic Heart Failure (CHF) | Mortality | 0 |
10-015-04 | Yoon 2010 - LCTx | Yoon | 2010 | Chronic Heart Failure (CHF) | Mortality | 0 |
10-015-03 | Yoon 2010 - CABG + SVR | Yoon | 2010 | Chronic Heart Failure (CHF) | Mortality | 0 |
10-015-02 | Yoon 2010 - CABG + MVA | Yoon | 2010 | Chronic Heart Failure (CHF) | Mortality | 0 |
10-015-01 | Yoon 2010 - CABG | Yoon | 2010 | Chronic Heart Failure (CHF) | Mortality | 0 |
11-035-02 | Yeh 2011 - Including Angiographic Characteristics | Yeh | 2011 | Coronary Artery Disease (CAD) | Revascularization | 0 |
11-035-01 | Yeh 2011 - Excluding Angiographic Characteristics | Yeh | 2011 | Coronary Artery Disease (CAD) | Revascularization | 0 |
13-061-01 | Yatsuya 2013 | Yatsuya | 2013 | Population Sample | Stroke | 1 |
11-025-01 | Yap 2011 | Yap | 2011 | Congenital Heart Disease | Mortality | 0 |
08-021-03 | Yap 2008 - Non-Arrhythmic Mortality | Yap | 2008 | Coronary Artery Disease (CAD) | Mortality | 0 |
08-021-02 | Yap 2008 - Arrhythmic Mortality | Yap | 2008 | Coronary Artery Disease (CAD) | Mortality | 0 |
08-021-01 | Yap 2008 - All-Cause Mortality | Yap | 2008 | Coronary Artery Disease (CAD) | Mortality | 0 |
08-038-01 | Yang 2008 | Yang | 2008 | Population Sample | Chronic Heart Failure (CHF) | 0 |
07-003-01 | Yang 2007 | Yang | 2007 | Population Sample | Stroke | 0 |
09-002-01 | Yamaki 2009 | Yamaki | 2009 | Venous Thromboembolism (VTE) | Composite | 0 |
05-022-01 | Yale 2005 | Yale | 2005 | Population Sample | Venous Thromboembolism (VTE) | 0 |
06-019-01 | Xu 2006 | Xu | 2006 | Cardiac Surgery | Prolonged LOS | 0 |
08-035-01 | Xanthos 2008 | Xanthos | 2008 | Arrhythmia | Arrhythmia | 0 |
04-013-01 | Wylie 2004 | Wylie | 2004 | Coronary Artery Disease (CAD) | Chronic Heart Failure (CHF) | 1 |
14-034-03 | Wu 2014 - 5 Years | Wu | 2014 | Coronary Artery Disease (CAD) | Mortality | 0 |
14-034-02 | Wu 2014 - 3 Years | Wu | 2014 | Coronary Artery Disease (CAD) | Mortality | 0 |
14-034-01 | Wu 2014 - 1 Year | Wu | 2014 | Coronary Artery Disease (CAD) | Mortality | 0 |
12-013-04 | Wu 2012 - 7 Years | Wu | 2012 | Coronary Artery Disease (CAD) | Mortality | 0 |
12-013-03 | Wu 2012 - 5 Years | Wu | 2012 | Coronary Artery Disease (CAD) | Mortality | 0 |
12-013-02 | Wu 2012 - 3 Years | Wu | 2012 | Coronary Artery Disease (CAD) | Mortality | 0 |
12-013-01 | Wu 2012 - 1 Year | Wu | 2012 | Coronary Artery Disease (CAD) | Mortality | 0 |
11-043-02 | Wu 2011 - Women | Wu | 2011 | Population Sample | Stroke | 0 |
11-043-01 | Wu 2011 - Men | Wu | 2011 | Population Sample | Stroke | 0 |
10-039-01 | Wu 2010 | Wu | 2010 | Cardiac Surgery | Mortality | 0 |
06-034-02 | Wu 2006 - Women, Simplified Evaluation Sheet | Wu | 2006 | Population Sample | Composite | 1 |
06-034-04 | Wu 2006 - Women, Full Equation | Wu | 2006 | Population Sample | Composite | 1 |
06-034-01 | Wu 2006 - Men, Simplified Evaluation Sheet | Wu | 2006 | Population Sample | Composite | 1 |
06-034-03 | Wu 2006 - Men, Full Equation | Wu | 2006 | Population Sample | Composite | 1 |
04-002-01 | Wu 2004 - Training Model | Wu | 2004 | Coronary Artery Disease (CAD) | Mortality | 0 |
04-002-02 | Wu 2004 - Final Model (All CABG) | Wu | 2004 | Coronary Artery Disease (CAD) | Mortality | 1 |
92-001-01 | Woodhouse 1992 | Woodhouse | 1992 | Cardiac Arrest | Mortality | 0 |
05-029-01 | Wongchareon 2005 | Wongchareon | 2005 | Chronic Heart Failure (CHF) | Chronic Heart Failure (CHF) | 0 |
10-041-01 | Wong 2010 | Wong | 2010 | Coronary Artery Disease (CAD) | Acute Coronary Syndrome (ACS) | 1 |
11-037-01 | Woller 2011 | Woller | 2011 | Population Sample | Venous Thromboembolism (VTE) | 1 |
13-088-01 | Wimmer 2013 | Wimmer | 2013 | Coronary Artery Disease (CAD) | Hemorrhage | 0 |
12-049-01 | Wimmer 2012 | Wimmer | 2012 | Carotid Disease | MANE | 0 |
12-028-01 | Wilson 2012 - Next Cardiovascular Event | Wilson | 2012 | Cardiovascular Disease (CVD) | MACCE | 0 |
12-028-02 | Wilson 2012 - Cardiovascular Death | Wilson | 2012 | Cardiovascular Disease (CVD) | Mortality | 0 |
08-004-01 | Wilson 2008 - CHD | Wilson | 2008 | Population Sample | MACE | 0 |
08-004-02 | Wilson 2008 - CeVD | Wilson | 2008 | Population Sample | MANE | 0 |
06-012-01 | Williams 2006 | Williams | 2006 | Coronary Artery Disease (CAD) | Mortality | 1 |
91-004-01 | Wilcox 1991 | Wilcox | 1991 | Coronary Artery Disease (CAD) | MACE | 0 |
12-087-03 | Widyastuti 2012 - Model III, Preop + Intraop | Widyastuti | 2012 | Cardiac Surgery | Prolonged Ventilation | 0 |
12-087-02 | Widyastuti 2012 - Model II, Preop + Intraop | Widyastuti | 2012 | Cardiac Surgery | Prolonged Ventilation | 0 |
12-087-01 | Widyastuti 2012 - Model I, Preop | Widyastuti | 2012 | Cardiac Surgery | Prolonged Ventilation | 0 |
12-070-03 | Widyastuti 2012 - Model 3 | Widyastuti | 2012 | Cardiac Surgery | Post-Operative Shock | 0 |
12-070-02 | Widyastuti 2012 - Model 2 | Widyastuti | 2012 | Cardiac Surgery | Post-Operative Shock | 0 |
12-070-01 | Widyastuti 2012 - Model 1 | Widyastuti | 2012 | Cardiac Surgery | Post-Operative Shock | 0 |
01-001-01 | Wicki 2001 | Wicki | 2001 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 5 |
14-043-01 | Whiteley 2014 | Whiteley | 2014 | Stroke | Stroke | 0 |
02-013-01 | West 2002 | West | 2002 | Coronary Artery Disease (CAD) | Stroke | 0 |
97-014-01 | Wells Score 1997 | Wells | 1997 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 2 |
95-007-01 | Wells Score | Wells | 1995 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 6 |
98-001-01 | Wells 1998 | Wells | 1998 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 0 |
12-088-01 | Weiss 2012 | Weiss | 2012 | Heart Transplant | Mortality | 4 |
11-032-01 | Weiss 2011 | Weiss | 2011 | Heart Transplant | Mortality | 4 |
06-037-01 | Weimar 2006 | Weimar | 2006 | Stroke | Functional Outcome | 2 |
10-028-01 | Wei 2010 | Wei | 2010 | Chest Pain | MACE | 1 |
98-004-01 | Wardlaw 1998 | Wardlaw | 1998 | Stroke | Mortality | 0 |
13-065-01 | Wang 2013 | Wang | 2013 | Coronary Artery Disease (CAD) | No Reflow | 1 |
13-014-01 | Wang 2013 | Wang | 2013 | Valve Disease | Prolonged Ventilation | 0 |
13-081-01 | Wang 2013 | Wang | 2013 | Chronic Heart Failure (CHF) | Renal Outcomes | 0 |
12-066-02 | Wang 2012 - Model 2 | Wang | 2012 | Chronic Heart Failure (CHF) | Right Ventricular Failure | 0 |
12-066-01 | Wang 2012 - Model 1 | Wang | 2012 | Chronic Heart Failure (CHF) | Right Ventricular Failure | 0 |
12-034-04 | Wang 2012 - 30 Day Imminent Death | Wang | 2012 | Chronic Heart Failure (CHF) | Mortality | 0 |
12-034-03 | Wang 2012 - 30 Day Hospitalization | Wang | 2012 | Chronic Heart Failure (CHF) | Hospitalization | 0 |
12-034-02 | Wang 2012 - 1 Year Imminent Death | Wang | 2012 | Chronic Heart Failure (CHF) | Mortality | 0 |
12-034-01 | Wang 2012 - 1 Year Hospitalization | Wang | 2012 | Chronic Heart Failure (CHF) | Hospitalization | 0 |
12-037-01 | Wang 2012 | Wang | 2012 | Valve Disease | Prolonged LOS | 0 |
01-012-01 | Wang 2001 | Wang | 2001 | Stroke | Mortality | 0 |
13-022-01 | Wallmann 2013 | Wallmann | 2013 | Population Sample | Hospitalization | 0 |
13-063-01 | Wallaert 2013 | Wallaert | 2013 | Carotid Disease | Mortality | 0 |
14-013-02 | Wakasa 2014 - Readmission and All Cause Mortality | Wakasa | 2014 | Chronic Heart Failure (CHF) | Composite | 0 |
14-013-01 | Wakasa 2014 - All Cause Mortality | Wakasa | 2014 | Chronic Heart Failure (CHF) | Mortality | 0 |
00-014-01 | von Kodolitsch 2000 | von Kodolitsch | 2000 | Chest Pain | Aortic Dissection | 0 |
09-042-01 | Volschan 2009 | Volschan | 2009 | Venous Thromboembolism (VTE) | Mortality | 0 |
13-052-01 | Vlak 2013 | Vlak | 2013 | Stroke | Hemorrhage | 0 |
10-026-02 | Vienna Prediction Model - 5 Years | Eichinger | 2010 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 1 |
10-026-01 | Vienna Prediction Model - 1 Year | Eichinger | 2010 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 1 |
14-005-01 | VIenna and Ludwigshafen Coronary Artery Disease (VILCAD) biomarker score (With LVEF) | Kleber | 2014 | Coronary Artery Disease (CAD) | Mortality | 0 |
93-005-01 | Veterans Affairs Medical Center (VAMC) Score | Morrow | 1993 | Coronary Artery Disease (CAD) | MACE | 1 |
11-054-01 | Verheugt 2011 | Verheugt | 2011 | Congenital Heart Disease | Endocarditis | 0 |
09-020-01 | Vemulapalli 2009 | Vemulapalli | 2009 | Cancer | Venous Thromboembolism (VTE) | 0 |
10-001-01 | Velavan 2010 | Velavan | 2010 | Chronic Heart Failure (CHF) | Mortality | 0 |
09-006-01 | Vazquez 2009 - Total Mortality | Vazquez | 2009 | Chronic Heart Failure (CHF) | Mortality | 0 |
09-006-04 | Vazquez 2009 - Sudden Death | Vazquez | 2009 | Chronic Heart Failure (CHF) | Mortality | 0 |
09-006-03 | Vazquez 2009 - Pump Failure Death | Vazquez | 2009 | Chronic Heart Failure (CHF) | Mortality | 0 |
09-006-02 | Vazquez 2009 - Cardiac Mortality | Vazquez | 2009 | Chronic Heart Failure (CHF) | Mortality | 0 |
10-036-01 | Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) | Bertges | 2010 | Peripheral Vascular Disease (PVD) | MACE | 1 |
13-011-01 | Vascular Study Group of New England (VSGNE) RAAA Risk Score | Robinson | 2013 | Aortic Disease | Mortality | 1 |
11-011-01 | Vascular Governance North West (VGNW) Risk Score | Grant | 2011 | Aortic Disease | Mortality | 1 |
96-009-01 | Vanzetto 1996 - Major Events | Vanzetto | 1996 | Cardiac Surgery | MACE | 1 |
96-009-02 | Vanzetto 1996 - Any Events | Vanzetto | 1996 | Cardiac Surgery | MACE | 0 |
96-008-03 | Vancouver Score - Ruptured Aneurysm, Initial Survivors | Chen | 1996 | Aortic Disease | Mortality | 0 |
96-008-02 | Vancouver Score - Ruptured Aneurysm | Chen | 1996 | Aortic Disease | Mortality | 2 |
96-008-01 | Vancouver Score - Nonruptured Aneurysm | Chen | 1996 | Aortic Disease | Mortality | 0 |
06-040-01 | Vancouver Chest Pain Rule | Christenson | 2006 | Chest Pain | Coronary Artery Disease (CAD) | 2 |
03-030-01 | van Walraven 2003 | van Walraven | 2003 | Arrhythmia | Stroke | 3 |
12-016-01 | van Rees 2012 | van Rees | 2012 | Chronic Heart Failure (CHF) | Mortality | 0 |
12-005-01 | van Lammeren 2012 | van Lammeren | 2012 | Carotid Disease | MACCE | 0 |
12-036-01 | Van Hattum 2012 | Van Hattum | 2012 | Peripheral Vascular Disease (PVD) | MACCE+ | 0 |
02-009-01 | van Eck 2002 | van Eck | 2002 | Coronary Artery Disease (CAD) | Mortality | 0 |
13-023-01 | Van De Bruaene 2013 | Van De Bruaene | 2013 | Cardiac Surgery | Arrhythmia | 0 |
97-012-01 | Valenzuela 1997 | Valenzuela | 1997 | Cardiac Arrest | Mortality | 0 |
91-001-01 | Utrecht Bleeding Risk Score | Nieuwenhuis | 1991 | Venous Thromboembolism (VTE) | Hemorrhage | 1 |
99-011-01 | Urwin 1999 - Theater | Urwin | 1999 | Aortic Disease | Mortality | 0 |
99-011-02 | Urwin 1999 - ICU | Urwin | 1999 | Aortic Disease | Mortality | 0 |
99-011-03 | Urwin 1999 - 28 Days | Urwin | 1999 | Aortic Disease | Mortality | 0 |
99-011-04 | Urwin 1999 - 100 Days | Urwin | 1999 | Aortic Disease | Mortality | 0 |
05-021-02 | Urbonavicius 2005 - Equation 2 | Urbonavicius | 2005 | Aortic Disease | Mortality | 0 |
05-021-01 | Urbonavicius 2005 - Equation 1 | Urbonavicius | 2005 | Aortic Disease | Mortality | 0 |
04-018-01 | Uppsala Longitudinal Study of Adult Men (ULSAM) Score | Dunder | 2004 | Population Sample | MACE | 0 |
91-013-01 | Updated Framingham | Anderson | 1991 | Population Sample | Coronary Artery Disease (CAD) | 2 |
13-031-01 | Updated CathPCI Registry Mortality Model | Brennan | 2013 | Coronary Artery Disease (CAD) | Mortality | 0 |
03-002-01 | Upchurch 2003 | Upchurch | 2003 | Aortic Disease | MACE+ | 0 |
01-011-01 | University of Michigan Model | Moscucci | 2001 | Coronary Artery Disease (CAD) | Mortality | 5 |
01-022-01 | UK Prospective Diabetes Study (UKPDS) | Stevens | 2001 | Population Sample | MACE | 11 |
92-011-08 | Tuman Risk Index - Serious Infection | Tuman | 1992 | Cardiac Surgery | Infection | 0 |
92-011-06 | Tuman Risk Index - Renal Insufficiency | Tuman | 1992 | Cardiac Surgery | Renal Outcomes | 0 |
92-011-05 | Tuman Risk Index - Pulmonary Complications | Tuman | 1992 | Cardiac Surgery | Pulmonary Complications | 0 |
92-011-03 | Tuman Risk Index - Perioperative MI | Tuman | 1992 | Cardiac Surgery | Myocardial Infarction (MI) | 0 |
92-011-10 | Tuman Risk Index - Overall Mortality | Tuman | 1992 | Cardiac Surgery | Mortality | 1 |
92-011-09 | Tuman Risk Index - Operative Mortality | Tuman | 1992 | Cardiac Surgery | Mortality | 0 |
92-011-02 | Tuman Risk Index - Morbidity (>=2 Complications) | Tuman | 1992 | Cardiac Surgery | Composite | 0 |
92-011-01 | Tuman Risk Index - Morbidity (>=1 Complication) | Tuman | 1992 | Cardiac Surgery | Composite | 2 |
92-011-04 | Tuman Risk Index - Low CO State | Tuman | 1992 | Cardiac Surgery | Low CO State | 0 |
92-011-07 | Tuman Risk Index - CNS Complications | Tuman | 1992 | Cardiac Surgery | CNS Complications | 0 |
99-019-01 | Tuhrim 1999 | Tuhrim | 1999 | Stroke | Mortality | 2 |
03-020-02 | Tu 2003 - Nonfatal Stroke | Tu | 2003 | Carotid Disease | Stroke | 0 |
03-020-03 | Tu 2003 - Death or Stroke | Tu | 2003 | Carotid Disease | MANE | 1 |
03-020-01 | Tu 2003 - Death | Tu | 2003 | Carotid Disease | Mortality | 0 |
15-001-01 | Trujillo-Santos 2015 | Trujillo-Santos | 2015 | Venous Thromboembolism (VTE) | Composite | 0 |
06-025-01 | Trujillo-Santos 2006 | Trujillo-Santos | 2006 | Venous Thromboembolism (VTE) | Composite | 0 |
93-007-01 | Tremblay 1993 | Tremblay | 1993 | Cardiac Surgery | Mortality | 2 |
06-045-01 | Transfusion Risk Understanding Scoring Tool (TRUST) | Alghamdi | 2006 | cardiac surgery | Transfusion | 0 |
09-051-01 | Transfusion Risk and Clinical Knowledge (TRACK) Score | Ranucci | 2009 | Cardiac Surgery | Transfusion | 0 |
10-022-01 | Totaled Health Risks in Vascular Events (THRIVE) | Flint | 2010 | Stroke | Functional Outcome | 23 |
11-024-01 | Total Burden Score (TBS) | Xie | 2011 | Population Sample | MACCE | 0 |
06-014-01 | Toronto Risk Score (TRS) | Ivanov | 2006 | Cardiac Surgery | MACCE+ | 1 |
09-003-01 | Toronto PCI Mortality Risk Score | Chowdhary | 2009 | Coronary Artery Disease (CAD) | Mortality | 1 |
13-103-01 | Tolonen 2013 | Tolonen | 2013 | Chronic Heart Failure (CHF) | Composite | 0 |
14-006-01 | Tolenaar 2014 | Tolenaar | 2014 | Aortic Disease | Mortality | 0 |
00-015-03 | Thrombolysis in Myocardial Infarction (TIMI) Risk Score for ST-elevation myocardial infarction (STEMI) - In Hospital | Morrow | 2000 | Coronary Artery Disease (CAD) | Mortality | 4 |
00-015-04 | Thrombolysis in Myocardial Infarction (TIMI) Risk Score for ST-elevation myocardial infarction (STEMI) - 6 Months | Morrow | 2000 | Coronary Artery Disease (CAD) | Mortality | 1 |
00-015-01 | Thrombolysis in Myocardial Infarction (TIMI) Risk Score for ST-elevation myocardial infarction (STEMI) - 30 Days | Morrow | 2000 | Coronary Artery Disease (CAD) | Mortality | 12 |
00-015-02 | Thrombolysis in Myocardial Infarction (TIMI) Risk Score for ST-elevation myocardial infarction (STEMI) - 24 Hours | Morrow | 2000 | Coronary Artery Disease (CAD) | Mortality | 0 |
00-015-05 | Thrombolysis in Myocardial Infarction (TIMI) Risk Score for ST-elevation myocardial infarction (STEMI) - 1 Year | Morrow | 2000 | Coronary Artery Disease (CAD) | Mortality | 7 |
00-012-05 | Thrombolysis in Myocardial Infarction (TIMI) Risk Score for non-ST-segment elevation myocardial infarction/ unstable angina (NSTEMI/UA)- All Cause Mortality or Nonfatal MI | Antman | 2000 | Coronary Artery Disease (CAD) | MACE | 4 |
00-012-04 | Thrombolysis in Myocardial Infarction (TIMI) Risk Score for non-ST-segment elevation myocardial infarction/ unstable angina (NSTEMI/UA) - Urgent Revascularization | Antman | 2000 | Coronary Artery Disease (CAD) | MACE | 0 |
00-012-03 | Thrombolysis in Myocardial Infarction (TIMI) Risk Score for non-ST-segment elevation myocardial infarction/ unstable angina (NSTEMI/UA) - Myocardial Infarction | Antman | 2000 | Coronary Artery Disease (CAD) | MACE | 0 |
00-012-01 | Thrombolysis in Myocardial Infarction (TIMI) Risk Score for non-ST-segment elevation myocardial infarction/ unstable angina (NSTEMI/UA) - Composite Endpoint | Antman | 2000 | Coronary Artery Disease (CAD) | MACE | 20 |
00-012-02 | Thrombolysis in Myocardial Infarction (TIMI) Risk Score for non-ST-segment elevation myocardial infarction/ unstable angina (NSTEMI/UA) - All Cause Mortality | Antman | 2000 | Coronary Artery Disease (CAD) | Mortality | 12 |
05-033-01 | Thrombolysis In Myocardial Infarction (TIMI) for ST-segment elevation myocardial infarction (STEMI) + C-reactive
protein (CRP) | Foussas | 2005 | Coronary Artery Disease (CAD) | Mortality | 0 |
05-033-02 | Thrombolysis In Myocardial Infarction (TIMI) for non-ST-segment elevation myocardial infarction (NSTEMI) + C-reactive
protein (CRP) | Foussas | 2005 | Coronary Artery Disease (CAD) | MACE | 1 |
90-004-01 | Thrombolysis in Myocardial Infarction (TIMI) | Hillis | 1990 | Coronary Artery Disease (CAD) | Mortality | 1 |
01-008-01 | Three-Item Scale | Baird | 2001 | Stroke | Functional Outcome | 2 |
10-054-01 | Thoracic Revised Cardiac Risk Index (ThRCRI) | Brunelli | 2010 | Population Sample | MACE | 3 |
93-003-01 | Thompson 1993 | Thompson | 1993 | Coronary Artery Disease (CAD) | MACE | 0 |
09-044-01 | Thai Venous Stroke Prognostic Score (TV-SPSS) | Poungvarin | 2009 | Stroke | Functional Outcome | 0 |
08-001-01 | Texas Heart Institute Risk Score | Madan | 2008 | Coronary Artery Disease (CAD) | MACCE | 1 |
13-045-01 | Takeda 2013 | Takeda | 2013 | Stroke | Hematoma Expansion | 0 |
03-011-04 | Systematic COronary Risk Evaluation (SCORE)- Low Risk, HDL Cholesterol | Conroy | 2003 | Population Sample | Mortality | 1 |
03-011-01 | Systematic COronary Risk Evaluation (SCORE)- High Risk, Total Cholesterol | Conroy | 2003 | Population Sample | Mortality | 16 |
03-011-02 | Systematic COronary Risk Evaluation (SCORE) - Low Risk, Total Cholesterol | Conroy | 2003 | Population Sample | Mortality | 19 |
03-011-03 | Systematic COronary Risk Evaluation (SCORE) - High Risk, HDL Cholesterol | Conroy | 2003 | Population Sample | Mortality | 0 |
13-110-01 | Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) II Score | Farooq | 2013 | Coronary Artery Disease (CAD) | Mortality | 7 |
14-068-01 | Symptomatic hemorrhage, baseline National Institutes of Health Stroke Scale score, Age, Reperfusion, and Location of clot (SNARL) | Prabhakaran | 2014 | Stroke | Functional Outcome | 1 |
11-001-02 | Sy 2011 - Day 8 | Sy | 2011 | Endocarditis | Mortality | 1 |
11-001-03 | Sy 2011 - Day 15 | Sy | 2011 | Endocarditis | Mortality | 1 |
11-001-01 | Sy 2011 - Day 1 | Sy | 2011 | Endocarditis | Mortality | 1 |
08-003-01 | Swedish National Diabetes Registry (NDR) Risk Score | Cederholm | 2008 | Population Sample | Composite | 3 |
13-076-01 | Sutter 2013 | Sutter | 2013 | Chest Pain | MACE | 0 |
14-008-02 | Survival posT-TAVI (STT) - 30 Days | D'Ascenzo | 2014 | Valve Disease | Mortality | 2 |
14-008-01 | Survival posT-TAVI (STT) - 1 Year | D'Ascenzo | 2014 | Valve Disease | Mortality | 2 |
12-089-01 | SURgical replacement and Transcatheter Aortic Valve Implantation (SURTAVI) Model | van Mieghem | 2012 | Cardiac Surgery | Mortality | 1 |
09-036-01 | Sun 2009 | Sun | 2009 | Syncope | MACCE | 0 |
13-003-01 | Sumi 2013 - Recurrent Ischemic Stroke | Sumi | 2013 | Stroke | Stroke | 0 |
13-003-02 | Sumi 2013 - Cardiovascular Events | Sumi | 2013 | Stroke | MACCE | 0 |
11-020-02 | Subramanian 2011 - Standard Baseline Measurements + Baseline Cytokines | Subramanian | 2011 | Chronic Heart Failure (CHF) | Mortality | 0 |
11-020-01 | Subramanian 2011 - Standard Baseline Measurements | Subramanian | 2011 | Chronic Heart Failure (CHF) | Mortality | 0 |
11-020-03 | Subramanian 2011 - Standard Baseline Measurement + Cytokines at Baseline and 8, 16, and 24 Weeks | Subramanian | 2011 | Chronic Heart Failure (CHF) | Mortality | 0 |
06-027-01 | Subarachnoid Hemorrhage (SAH) Prognosis Score | Mocco | 2006 | Stroke | Mortality | 0 |
11-014-02 | Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisations in Seniors with Heart Failure (SENIORS) - Mortality | Manzano | 2011 | Chronic Heart Failure (CHF) | Mortality | 1 |
11-014-01 | Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisations in Seniors with Heart Failure (SENIORS) - Admission/Mortality | Manzano | 2011 | Chronic Heart Failure (CHF) | Composite | 1 |
91-014-04 | Study of Cardiovascular Risks in Adolescents (ERICA) - West Region | ERICA Research Group | 1991 | Population Sample | Mortality | 0 |
91-014-05 | Study of Cardiovascular Risks in Adolescents (ERICA) - South Region | ERICA Research Group | 1991 | Population Sample | Mortality | 0 |
91-014-01 | Study of Cardiovascular Risks in Adolescents (ERICA) - North Region | ERICA Research Group | 1991 | Population Sample | Mortality | 0 |
91-014-03 | Study of Cardiovascular Risks in Adolescents (ERICA) - Europe | ERICA Research Group | 1991 | Population Sample | Mortality | 1 |
91-014-02 | Study of Cardiovascular Risks in Adolescents (ERICA) - East Region | ERICA Research Group | 1991 | Population Sample | Mortality | 0 |
06-032-01 | Stroke Thrombolytic Predictive Instrument (TPI) - Good Outcome | Kent | 2006 | Stroke | Functional Outcome | 5 |
06-032-03 | Stroke Thrombolytic Predictive Instrument (TPI) - Catastrophic Outcome (Model with ASPECTS) | Kent | 2006 | Stroke | Functional Outcome | 0 |
06-032-02 | Stroke Thrombolytic Predictive Instrument (TPI) - Catastrophic Outcome (Clinical Model) | Kent | 2006 | Stroke | Functional Outcome | 3 |
14-063-01 | Stroke subtype, Oxford Community Stroke Project classification, Age, prestroke modified Rankin (SOAR) Score - In Hospital | Myint | 2014 | Stroke | Mortality | 3 |
14-063-02 | Stroke subtype, Oxford Community Stroke Project classification, Age, prestroke modified Rankin (SOAR) Score - 7 Days | Myint | 2014 | Stroke | Mortality | 1 |
13-107-01 | Stroke Prognostication using Age and NIH Stroke Scale (SPAN)-100 - ICH | Saposnik | 2013 | Stroke | Stroke | 6 |
13-107-02 | Stroke Prognostication using Age and NIH Stroke Scale (SPAN)-100 - Favorable Outcome | Saposnik | 2013 | Stroke | Functional Outcome | 5 |
00-020-01 | Stroke Prognosis Instrument II (SPI-II) | Kernan | 2000 | Stroke | MANE | 5 |
91-009-01 | Stroke Prognosis Instrument (SPI-I) | Kernan | 1991 | Stroke | MANE | 2 |
99-004-01 | Stroke Prevention in Atrial Fibrillation (SPAF) | Hart | 1999 | Arrhythmia | Stroke | 2 |
13-001-01 | Stovring 2013 - CVD Mortality | Stovring | 2013 | Population Sample | Mortality | 0 |
13-001-02 | Stovring 2013 - All-Cause Mortality | Stovring | 2013 | Population Sample | Mortality | 0 |
13-077-02 | Stiell 2013 - Model Excluding NT-proBNP | Stiell | 2013 | Chronic Heart Failure (CHF) | MACE+ | 0 |
12-047-01 | Stavrakis 2012 | Stavrakis | 2012 | Population Sample | Mortality | 0 |
99-005-01 | Staat 1999 | Staat | 1999 | Coronary Artery Disease (CAD) | MACCE+ | 0 |
13-097-01 | St. George's Vascular Institute Risk Score | Karthikesalingam | 2013 | Aortic Disease | Composite | 1 |
02-007-01 | SSV Model - Survival | Counsell | 2002 | Stroke | Mortality | 4 |
02-007-02 | SSV Model - Independent Survival | Counsell | 2002 | Stroke | Mortality | 9 |
09-041-01 | Sprengers 2009 | Sprengers | 2009 | Peripheral Vascular Disease (PVD) | MACCE | 0 |
09-040-01 | spontaneous intracerebral hemorrhage (sICH) | Chuang | 2009 | Stroke | Mortality | 2 |
12-026-02 | Soveri 2012 - Mortality | Soveri | 2012 | Miscellaneous | Mortality | 1 |
12-026-01 | Soveri 2012 - MACE | Soveri | 2012 | Miscellaneous | MACE | 1 |
13-037-01 | South African Vascular Surgical Cardiac Risk Index (SAVS-CRI) | Moodley | 2013 | Post-Operative | Composite | 0 |
12-082-01 | Soroka Acute Myocardial Infarction (SAMI) Risk Score | Plakht | 2012 | Coronary Artery Disease (CAD) | Mortality | 0 |
02-002-01 | Solomon 2002 | Solomon | 2002 | Coronary Artery Disease (CAD) | Coronary Artery Disease (CAD) | 0 |
01-018-01 | Solomon 2001 | Solomon | 2001 | Coronary Artery Disease (CAD) | MACE | 0 |
07-026-03 | Solberg 2007 - 4-Variable Model | Solberg | 2007 | Stroke | Mortality | 0 |
07-026-02 | Solberg 2007 - 3-Variable Model | Solberg | 2007 | Stroke | Mortality | 0 |
07-026-01 | Solberg 2007 - 2-Variable Model | Solberg | 2007 | Stroke | Mortality | 0 |
05-023-01 | Society of Thoracic Surgeons (STS) for Surgical Site Infection (SSI) - Preoperative | Fowler | 2005 | Coronary Artery Disease (CAD) | Infection | 1 |
05-023-02 | Society of Thoracic Surgeons (STS) for Surgical Site Infection (SSI) - Combined | Fowler | 2005 | Coronary Artery Disease (CAD) | Infection | 1 |
09-028-04 | Society of Thoracic Surgeons (STS) (valve) - Ventilation | O'Brien | 2009 | Cardiac Surgery | Prolonged Ventilation | 4 |
09-028-02 | Society of Thoracic Surgeons (STS) (valve) - Stroke | O'Brien | 2009 | Cardiac Surgery | Stroke | 4 |
09-028-09 | Society of Thoracic Surgeons (STS) (valve) - Short LOS | O'Brien | 2009 | Cardiac Surgery | Short LOS | 2 |
09-028-06 | Society of Thoracic Surgeons (STS) (valve) - Reoperation | O'Brien | 2009 | Cardiac Surgery | Reoperation | 3 |
09-028-03 | Society of Thoracic Surgeons (STS) (valve) - Renal Failure | O'Brien | 2009 | Cardiac Surgery | Renal Outcomes | 4 |
09-028-08 | Society of Thoracic Surgeons (STS) (valve) - Prolonged LOS | O'Brien | 2009 | Cardiac Surgery | Prolonged LOS | 6 |
09-028-01 | Society of Thoracic Surgeons (STS) (valve) - Mortality | O'Brien | 2009 | Cardiac Surgery | Mortality | 51 |
09-028-05 | Society of Thoracic Surgeons (STS) (valve) - DSWI | O'Brien | 2009 | Cardiac Surgery | Infection | 3 |
09-028-07 | Society of Thoracic Surgeons (STS) (valve) - Composite | O'Brien | 2009 | Cardiac Surgery | Composite | 3 |
01-028-01 | Society of Thoracic Surgeons (STS) (original) - isolated valve | Edwards | 2001 | Valve Disease | Mortality | 0 |
13-068-02 | Society of Thoracic Surgeons (STS) (Multiple Valve) - Preop MT | Rankin | 2013 | Valve Disease | Mortality | 1 |
13-068-03 | Society of Thoracic Surgeons (STS) (Multiple Valve) - Preop AMT | Rankin | 2013 | Valve Disease | Mortality | 1 |
13-068-01 | Society of Thoracic Surgeons (STS) (Multiple Valve) - Preop AM | Rankin | 2013 | Valve Disease | Mortality | 1 |
13-068-05 | Society of Thoracic Surgeons (STS) (Multiple Valve) - Preop + Intraop MT | Rankin | 2013 | Valve Disease | Mortality | 1 |
13-068-06 | Society of Thoracic Surgeons (STS) (Multiple Valve) - Preop + Intraop AMT | Rankin | 2013 | Valve Disease | Mortality | 1 |
13-068-04 | Society of Thoracic Surgeons (STS) (Multiple Valve) - Preop + Intraop AM | Rankin | 2013 | Valve Disease | Mortality | 1 |
09-052-04 | Society of Thoracic Surgeons (STS) (Isolated CABG) - Ventilation | Shahian | 2009 | Cardiac Surgery | Prolonged Ventilation | 1 |
09-052-09 | Society of Thoracic Surgeons (STS) (Isolated CABG) - Short LOS | Shahian | 2009 | Cardiac Surgery | Short LOS | 1 |
09-052-06 | Society of Thoracic Surgeons (STS) (Isolated CABG) - Reoperation | Shahian | 2009 | Cardiac Surgery | Reoperation | 1 |
09-052-03 | Society of Thoracic Surgeons (STS) (Isolated CABG) - Renal Failure | Shahian | 2009 | Cardiac Surgery | Renal Outcomes | 1 |
09-052-08 | Society of Thoracic Surgeons (STS) (Isolated CABG) - Prolonged LOS | Shahian | 2009 | Cardiac Surgery | Prolonged LOS | 1 |
09-052-01 | Society of Thoracic Surgeons (STS) (Isolated CABG) - Mortality | Shahian | 2009 | Cardiac Surgery | Mortality | 1 |
09-052-05 | Society of Thoracic Surgeons (STS) (Isolated CABG) - DSWI | Shahian | 2009 | Cardiac Surgery | Infection | 1 |
09-052-02 | Society of Thoracic Surgeons (STS) (Isolated CABG) - CVA | Shahian | 2009 | Cardiac Surgery | Stroke | 1 |
09-052-07 | Society of Thoracic Surgeons (STS) (Isolated CABG) - Composite | Shahian | 2009 | Cardiac Surgery | Composite | 1 |
09-029-09 | Society of Thoracic Surgeons (STS) (CABG/valve) - Short LOS | Shahian | 2009 | Coronary Artery Disease (CAD) | Short LOS | 1 |
09-029-06 | Society of Thoracic Surgeons (STS) (CABG/valve) - Reoperation | Shahian | 2009 | Coronary Artery Disease (CAD) | Reoperation | 1 |
09-029-03 | Society of Thoracic Surgeons (STS) (CABG/valve) - Renal Failure | Shahian | 2009 | Coronary Artery Disease (CAD) | Renal Outcomes | 1 |
09-029-04 | Society of Thoracic Surgeons (STS) (CABG/valve) - Prolonged Ventilation | Shahian | 2009 | Coronary Artery Disease (CAD) | Prolonged Ventilation | 1 |
09-029-08 | Society of Thoracic Surgeons (STS) (CABG/valve) - Prolonged LOS | Shahian | 2009 | Coronary Artery Disease (CAD) | Prolonged LOS | 2 |
09-029-01 | Society of Thoracic Surgeons (STS) (CABG/valve) - Mortality | Shahian | 2009 | Coronary Artery Disease (CAD) | Mortality | 4 |
09-029-05 | Society of Thoracic Surgeons (STS) (CABG/valve) - DSWI | Shahian | 2009 | Coronary Artery Disease (CAD) | Infection | 1 |
09-029-02 | Society of Thoracic Surgeons (STS) (CABG/valve) - CVA | Shahian | 2009 | Coronary Artery Disease (CAD) | Stroke | 1 |
09-029-07 | Society of Thoracic Surgeons (STS) (CABG/valve) - Composite Adverse Event | Shahian | 2009 | Coronary Artery Disease (CAD) | Composite | 1 |
03-022-01 | Smits 2003 | Smits | 2003 | Chronic Heart Failure (CHF) | Mortality | 1 |
14-052-01 | Sladojevic 2014 | Sladojevic | 2014 | Coronary Artery Disease (CAD) | Mortality | 1 |
11-044-03 | Sladjana 2011 - SR-Serbian Quality of Life long-term (SR-QOLl) | Sladjana | 2011 | Cardiac Arrest | Mortality | 0 |
11-044-02 | Sladjana 2011 - Serbian Quality of Life short-term (SR-QOLs) | Sladjana | 2011 | Cardiac Arrest | Mortality | 0 |
11-044-01 | Sladjana 2011 - Serbian Quality of Life immediately (SR-QOLi) | Sladjana | 2011 | Cardiac Arrest | Mortality | 0 |
97-011-01 | Siu 1997 | Siu | 1997 | Pregnancy | Composite | 0 |
13-035-01 | SinoSCORE | Zheng | 2013 | Coronary Artery Disease (CAD) | Mortality | 0 |
13-104-06 | Sinning 2013 - Target Lesion Revascularization | Sinning | 2013 | Coronary Artery Disease (CAD) | Revascularization | 0 |
13-104-04 | Sinning 2013 - Stroke | Sinning | 2013 | Coronary Artery Disease (CAD) | Stroke | 0 |
13-104-05 | Sinning 2013 - Nonfatal MI | Sinning | 2013 | Coronary Artery Disease (CAD) | Myocardial Infarction (MI) | 0 |
13-104-01 | Sinning 2013 - First MACCE at 3 Years | Sinning | 2013 | Coronary Artery Disease (CAD) | MACCE | 0 |
13-104-03 | Sinning 2013 - Cardiac Mortality | Sinning | 2013 | Coronary Artery Disease (CAD) | Mortality | 0 |
13-104-07 | Sinning 2013 - Cardiac Hospitalization | Sinning | 2013 | Coronary Artery Disease (CAD) | Cardiac Hospitalization | 0 |
13-104-02 | Sinning 2013 - All Cause Mortality | Sinning | 2013 | Coronary Artery Disease (CAD) | Mortality | 0 |
12-073-05 | Sinning 2012 - Target Lesion Revascularization | Sinning | 2012 | Coronary Artery Disease (CAD) | Revascularization | 0 |
12-073-04 | Sinning 2012 - Nonfatal MI | Sinning | 2012 | Coronary Artery Disease (CAD) | Myocardial Infarction (MI) | 0 |
12-073-01 | Sinning 2012 - First MACE at 1 Year | Sinning | 2012 | Coronary Artery Disease (CAD) | MACE | 0 |
12-073-03 | Sinning 2012 - Cardiac Mortality | Sinning | 2012 | Coronary Artery Disease (CAD) | Mortality | 0 |
12-073-02 | Sinning 2012 - All Cause Mortality | Sinning | 2012 | Coronary Artery Disease (CAD) | Mortality | 0 |
12-074-01 | Singh 2012 - Recipient Variables | Singh | 2012 | Chronic Heart Failure (CHF) | Mortality | 1 |
12-074-02 | Singh 2012 - Recipient + Donor Variables | Singh | 2012 | Chronic Heart Failure (CHF) | Mortality | 1 |
10-048-02 | Singh 2010 - Mortality/MI | Singh | 2010 | Coronary Artery Disease (CAD) | MACE | 0 |
10-048-01 | Singh 2010 - Mortality | Singh | 2010 | Coronary Artery Disease (CAD) | Mortality | 0 |
09-034-01 | Singh 2009 | Singh | 2009 | Chronic Heart Failure (CHF) | Mortality | 1 |
05-024-01 | Singh 2005 | Singh | 2005 | Coronary Artery Disease (CAD) | MACCE | 0 |
00-005-01 | Simplified Wells Score | Wells | 2000 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 9 |
08-047-02 | Simplified Wells Rule | Gibson | 2008 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 1 |
15-006-06 | Simplified Stroke Thrombolytic Predictive Instrument (TPI) - mRS Score >=5 (Full NIHSS) | Kent | 2015 | Stroke | Functional Outcome | 0 |
15-006-09 | Simplified Stroke Thrombolytic Predictive Instrument (TPI) - mRS Score >=5 (8-Item NIHSS) | Kent | 2015 | Stroke | Functional Outcome | 0 |
15-006-03 | Simplified Stroke Thrombolytic Predictive Instrument (TPI) - mRS Score >=5 (3-item NIHSS) | Kent | 2015 | Stroke | Functional Outcome | 0 |
15-006-05 | Simplified Stroke Thrombolytic Predictive Instrument (TPI) - mRS Score <=2 (Full NIHSS) | Kent | 2015 | Stroke | Functional Outcome | 1 |
15-006-08 | Simplified Stroke Thrombolytic Predictive Instrument (TPI) - mRS Score <=2 (8-Item NIHSS) | Kent | 2015 | Stroke | Functional Outcome | 1 |
15-006-02 | Simplified Stroke Thrombolytic Predictive Instrument (TPI) - mRS Score <=2 (3-item NIHSS) | Kent | 2015 | Stroke | Functional Outcome | 1 |
15-006-04 | Simplified Stroke Thrombolytic Predictive Instrument (TPI) - mRS Score <=1 (Full NIHSS) | Kent | 2015 | Stroke | Functional Outcome | 1 |
15-006-07 | Simplified Stroke Thrombolytic Predictive Instrument (TPI) - mRS Score <=1 (8-Item NIHSS) | Kent | 2015 | Stroke | Functional Outcome | 1 |
15-006-01 | Simplified Stroke Thrombolytic Predictive Instrument (TPI) - mRS Score <=1 (3-item NIHSS) | Kent | 2015 | Stroke | Functional Outcome | 1 |
08-051-01 | Simplified Revised Geneva Score | Klok | 2008 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 1 |
10-056-01 | Simplified Pulmonary Embolism Severity Index (sPESI) | Jimenez | 2010 | Venous Thromboembolism (VTE) | Mortality | 11 |
13-057-01 | Simplified Model for End-stage Liver Disease (MELD) Score | Tsuda | 2013 | Valve Disease | Mortality | 0 |
13-058-02 | Simplified ASCORE (ASCORE-S) | Prieto-Merino | 2013 | Population Sample | MACCE | 0 |
00-022-01 | Simplified American College of Cardiology/American Heart Association (ACC/AHA) Lesion Classification - Major Complications | Krone | 2000 | Cardiac Surgery | MACE | 1 |
00-022-02 | Simplified American College of Cardiology/American Heart Association (ACC/AHA) Lesion Classification - In Hospital Death | Krone | 2000 | Cardiac Surgery | Mortality | 1 |
00-022-03 | Simplified American College of Cardiology/American Heart Association (ACC/AHA) Lesion Classification - Emergency CABG | Krone | 2000 | Cardiac Surgery | Revascularization | 0 |
14-014-01 | Simple Variables Model (SVM) | Seiffge | 2014 | Stroke | Functional Outcome | 0 |
01-021-01 | Simple Risk Index (SRI) | Morrow | 2001 | Coronary Artery Disease (CAD) | Mortality | 2 |
10-045-01 | Silva 2010 | Silva | 2010 | Cardiac Surgery | Arrhythmia | 1 |
10-031-01 | Siena Carotid Artery Stenting (CAS) Risk Score | Setacci | 2010 | Carotid Disease | Stroke | 0 |
06-035-01 | Shireman 2006 | Shireman | 2006 | Arrhythmia | Hemorrhage | 1 |
13-059-01 | Shirali 2013 | Shirali | 2013 | Population Sample | Aortic Dissection | 0 |
13-033-01 | Shibazaki 2013 | Shibazaki | 2013 | Stroke | Mortality | 0 |
10-051-01 | Shi 2010 | Shi | 2010 | Cardiac Surgery | Mortality | 0 |
14-047-01 | Severe Prediction Scoring (SPS) System | Chen | 2014 | Coronary Artery Disease (CAD) | Coronary Artery Disease (CAD) | 0 |
91-012-01 | Selker Time-Insensitive Predictive Instrument (TIPI) | Selker | 1991 | Chest Pain | Acute Coronary Syndrome (ACS) | 2 |
97-009-05 | Selker 1997 - Thrombolysis-Related Major Bleed | Selker | 1997 | Coronary Artery Disease (CAD) | Hemorrhage | 0 |
97-009-04 | Selker 1997 - Thrombolysis-Related Intracranial Hemorrhage | Selker | 1997 | Coronary Artery Disease (CAD) | Stroke | 0 |
97-009-03 | Selker 1997 - Cardiac Arrest | Selker | 1997 | Coronary Artery Disease (CAD) | Cardiac Arrest | 0 |
97-009-01 | Selker 1997 - 30-Day Mortality | Selker | 1997 | Coronary Artery Disease (CAD) | Mortality | 0 |
97-009-02 | Selker 1997 - 1-Year Mortality | Selker | 1997 | Coronary Artery Disease (CAD) | Mortality | 0 |
13-108-03 | Secondary Manifestations of ARTerial disease (SMART) Risk Score PLUS | Dorresteijn | 2013 | Coronary Artery Disease (CAD) | MACCE | 0 |
13-108-01 | Secondary Manifestations of ARTerial disease (SMART) Risk Score | Dorresteijn | 2013 | Coronary Artery Disease (CAD) | MACCE | 2 |
14-039-01 | Seattle Post Myocardial Infarction Model (SPIM) Score | Ketchum | 2014 | Coronary Artery Disease (CAD) | Mortality | 1 |
06-016-03 | Seattle Heart Failure Model (SHFM) - 5 Years | Levy | 2006 | Chronic Heart Failure (CHF) | Mortality | 7 |
06-016-02 | Seattle Heart Failure Model (SHFM) - 2 Years | Levy | 2006 | Chronic Heart Failure (CHF) | Mortality | 7 |
06-016-01 | Seattle Heart Failure Model (SHFM) - 1 Year | Levy | 2006 | Chronic Heart Failure (CHF) | Mortality | 16 |
12-030-02 | Scrutinio 2012 - Model 2 | Scrutinio | 2012 | Chronic Heart Failure (CHF) | Mortality | 0 |
12-030-01 | Scrutinio 2012 - Model 1 | Scrutinio | 2012 | Chronic Heart Failure (CHF) | Mortality | 0 |
06-023-01 | Schwaiger 2006 | Schwaiger | 2006 | Population Sample | MACCE | 0 |
08-012-01 | Schonwetter 2008 | Schonwetter | 2008 | Coronary Artery Disease (CAD) | Hospitalization | 0 |
13-078-01 | Schnabel 2013 | Schnabel | 2013 | Arrhythmia | Chronic Heart Failure (CHF) | 0 |
04-020-01 | Schmittling 2004 | Schmittling | 2004 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 0 |
13-075-01 | Schellinger 2013 | Schellinger | 2013 | Stroke | Functional Outcome | 0 |
12-035-01 | Scali 2012 | Scali | 2012 | Aortic Disease | Mortality | 0 |
03-026-01 | Sarasin 2003 | Sarasin | 2003 | Syncope | Arrhythmia | 1 |
09-043-01 | Santos 2009 | Santos | 2009 | Coronary Artery Disease (CAD) | MACE | 0 |
05-017-01 | Sanchis 2005 | Sanchis | 2005 | Chest Pain | MACE | 2 |
10-010-01 | Sanchez 2010 | Sanchez | 2010 | Venous Thromboembolism (VTE) | Composite | 0 |
04-025-01 | San Francisco Syncope Rule | Quinn | 2004 | Syncope | MACCE | 1 |
90-001-01 | Sahasakul 1990 | Sahasakul | 1990 | Coronary Artery Disease (CAD) | Mortality | 0 |
12-006-01 | Safe Implementation of Treatments in Stroke (SITS)- Symptomatic intracerebral hemorrhage (SICH) Risk Score | Mazya | 2012 | Stroke | Stroke | 9 |
04-015-01 | Sadanandan 2004 | Sadanandan | 2004 | Coronary Artery Disease (CAD) | Revascularization | 2 |
03-005-01 | Sabatine 2003 | Sabatine | 2003 | Coronary Artery Disease (CAD) | MACE | 5 |
11-034-01 | Sabate 2011 | Sabate | 2011 | Post-Operative | MACCE | 1 |
10-003-01 | S) severe hypertension, (C) confusion, (A) anticoagulation, (N) nausea and vomiting (SCAN) Rule | Lovelock | 2010 | Stroke | Stroke | 1 |
09-011-01 | Russo 2009 | Russo | 2009 | Heart Transplant | Composite | 0 |
02-004-01 | Russell 2002 - Women | Russell | 2002 | Population Sample | Venous Thromboembolism (VTE) | 0 |
02-004-02 | Russell 2002 - Men | Russell | 2002 | Population Sample | Venous Thromboembolism (VTE) | 0 |
99-008-02 | Rothwell 1999 - Surgical | Rothwell | 1999 | Stroke | MANE | 0 |
99-008-01 | Rothwell 1999 - Medical | Rothwell | 1999 | Stroke | Stroke | 0 |
07-027-01 | Roquer 2007 | Roquer | 2007 | Stroke | Mortality | 0 |
12-040-01 | Romond 2012 | Romond | 2012 | Cancer | MACE | 0 |
14-048-02 | Romano 2014 - 6 Months | Romano | 2014 | Coronary Artery Disease (CAD) | MACCE | 0 |
14-048-01 | Romano 2014 - 30 Days | Romano | 2014 | Coronary Artery Disease (CAD) | MACCE | 0 |
04-003-02 | Rohrig 2004 - Model 2 | Röhrig | 2004 | Post-Operative | Composite | 0 |
04-003-01 | Rohrig 2004 - Model 1 | Röhrig | 2004 | Post-Operative | Composite | 0 |
07-017-01 | Rogers 2007 | Rogers | 2007 | Post-Operative | Venous Thromboembolism (VTE) | 0 |
12-050-01 | Rodriguez-Pascual 2012 | Rodriguez-Pascual | 2012 | Chronic Heart Failure (CHF) | Mortality | 0 |
92-012-01 | Rodriguez 1992 | Rodriguez | 1992 | Cardiac Arrest | Arrhythmia | 1 |
02-008-01 | Rodrigues Alves 2002 | Rodrigues Alves | 2002 | Aortic Disease | Technical Success | 0 |
91-005-01 | Rodrigues 1991 | Rodrigues | 1991 | Stroke | Mortality | 0 |
14-053-01 | Rizzi 2014 | Rizzi | 2014 | Endocarditis | Composite | 0 |
11-002-01 | Rittenberger 2011 | Rittenberger | 2011 | Cardiac Arrest | Mortality | 0 |
13-017-01 | Risk of Paradoxical Embolism (RoPE) Score | Kent | 2013 | Stroke | Stroke | 0 |
06-011-01 | Risk Index Score (RISc) | Kass-Hout | 2006 | Stroke | Stroke | 0 |
08-041-01 | Right Ventricular Failure Risk Score (RVFRS) | Matthews | 2008 | Chronic Heart Failure (CHF) | Right Ventricular Failure | 0 |
08-013-01 | Ridker 2008 | Ridker | 2008 | Population Sample | MACCE | 0 |
03-007-01 | Ricotta 2003 | Ricotta | 2003 | Coronary Artery Disease (CAD) | Stroke | 1 |
13-043-01 | Richter 2013 | Richter | 2013 | Chronic Heart Failure (CHF) | Mortality | 0 |
07-015-01 | Richardson 2007 | Richardson | 2007 | Chronic Heart Failure (CHF) | Composite | 0 |
07-007-02 | Reynolds Risk Score (RRS) - Model B | Ridker | 2007 | Population Sample | MACCE | 1 |
07-007-01 | Reynolds Risk Score (RRS) - Model A | Ridker | 2007 | Population Sample | MACCE | 1 |
06-006-01 | Rexius 2006 | Rexius | 2006 | Coronary Artery Disease (CAD) | Mortality | 0 |
06-042-01 | Revised Geneva Score | Le Gal | 2006 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 3 |
99-012-01 | Revised Cardiac Risk Index (RCRI) | Lee | 1999 | Post-Operative | MACE | 13 |
03-001-02 | Resuscitation Predictor Scoring (RPS) Scale B | Cooper | 2003 | Cardiac Arrest | Mortality | 1 |
03-001-01 | Resuscitation Predictor Scoring (RPS) Scale A | Cooper | 2003 | Cardiac Arrest | Mortality | 0 |
01-007-02 | Resnic 2001 - Death, MI, or Bypass Surgery | Resnic | 2001 | Coronary Artery Disease (CAD) | MACE | 1 |
01-007-01 | Resnic 2001 - Death | Resnic | 2001 | Coronary Artery Disease (CAD) | Mortality | 2 |
13-016-01 | Renal dysfunction, CHF, Hypertension, Age, DM, History of Stroke or TIA (R2CHADS2) Score | Piccini | 2013 | Arrhythmia | Stroke | 7 |
12-004-06 | Reid 2012 - Model 6 | Reid | 2012 | Stroke | Functional Outcome | 0 |
12-004-05 | Reid 2012 - Model 5 | Reid | 2012 | Stroke | Functional Outcome | 0 |
12-004-04 | Reid 2012 - Model 4 | Reid | 2012 | Stroke | Functional Outcome | 0 |
12-004-03 | Reid 2012 - Model 3 | Reid | 2012 | Stroke | Functional Outcome | 0 |
12-004-02 | Reid 2012 - Model 2 | Reid | 2012 | Stroke | Functional Outcome | 1 |
12-004-01 | Reid 2012 - Model 1 | Reid | 2012 | Stroke | Functional Outcome | 0 |
10-023-03 | Reid 2010 - Model III (All CIVIC and Clinical Variables) | Reid | 2010 | Stroke | Functional Outcome | 0 |
10-023-02 | Reid 2010 - Model II (Clinical Variables Excluding Stroke Severity Score) | Reid | 2010 | Stroke | Functional Outcome | 2 |
10-023-01 | Reid 2010 - Model I (All Clinical Variables) | Reid | 2010 | Stroke | Functional Outcome | 1 |
08-005-01 | Registry of Patients with Venous Thromboembolism (RIETE) Score | Ruiz-Gimenez | 2008 | Venous Thromboembolism (VTE) | Hemorrhage | 2 |
10-019-01 | Reduction of Atherothrombosis for Continued Health (REACH) | Ducrocq | 2010 | Cardiovascular Disease (CVD) | Hemorrhage | 2 |
15-005-02 | Redin-SCORE - 1 Year | Alvarez-Garcia | 2015 | Chronic Heart Failure (CHF) | Chronic Heart Failure (CHF) | 1 |
15-005-01 | Redin-SCORE - 1 Month | Alvarez-Garcia | 2015 | Chronic Heart Failure (CHF) | Chronic Heart Failure (CHF) | 1 |
08-006-01 | Reddy 2008 | Reddy | 2008 | Stroke | Stroke | 1 |
07-023-01 | Reddy 2007 | Reddy | 2007 | Cardiac Surgery | Prolonged Ventilation | 0 |
11-045-01 | RED-AF Score | Barrett | 2011 | Arrhythmia | Composite | 1 |
10-012-02 | Recurrence Risk Estimator at 90 days (RRE-90) - Clinical + Imaging | Ay | 2010 | Stroke | Stroke | 3 |
10-012-01 | Recurrence Risk Estimator at 90 days (RRE-90) - Clinical | Ay | 2010 | Stroke | Stroke | 2 |
06-026-01 | Rassi 2006 | Rassi | 2006 | Chronic Heart Failure (CHF) | Mortality | 1 |
14-025-02 | Rapsomaniki 2014 - MI/CHD Death | Rapsomaniki | 2014 | Coronary Artery Disease (CAD) | MACE | 1 |
14-025-01 | Rapsomaniki 2014 - Death | Rapsomaniki | 2014 | Coronary Artery Disease (CAD) | Mortality | 1 |
13-036-01 | Rao 2013 | Rao | 2013 | Coronary Artery Disease (CAD) | Hemorrhage | 0 |
11-051-01 | Ramos 2011 - Derivation Dataset | Ramos | 2011 | Population Sample | PAD | 0 |
13-086-01 | Ramanan 2013 | Ramanan | 2013 | Aortic Disease | Mortality | 0 |
13-085-01 | Rahmanian 2013 | Rahmanian | 2013 | Cardiac Surgery | Mortality | 1 |
11-007-01 | Rahmanian 2011 | Rahmanian | 2011 | Cardiac Surgery | Renal Outcomes | 1 |
03-027-01 | Qureshi 2003 | Qureshi | 2003 | Coronary Artery Disease (CAD) | Mortality | 1 |
01-004-01 | Qureshi 2001 | Qureshi | 2001 | Population Sample | Coronary Artery Disease (CAD) | 2 |
00-008-01 | Qureshi 2000 | Qureshi | 2000 | Stroke | Vasospasm | 0 |
07-020-01 | QRISK1 - Women | Hippisley-Cox | 2007 | Population Sample | MACCE | 3 |
07-020-02 | QRISK1 - Men | Hippisley-Cox | 2007 | Population Sample | MACCE | 3 |
14-065-01 | Qbleed - ICH | Hippisley-Cox | 2014 | Population Sample | Stroke | 4 |
06-007-01 | Pulmonary Embolism Severity Index (PESI) 2006 | Aujesky | 2006 | Venous Thromboembolism (VTE) | Mortality | 7 |
05-015-01 | Pulmonary Embolism Severity Index (PESI) | Aujesky | 2005 | Venous Thromboembolism (VTE) | Mortality | 7 |
08-025-01 | Pulmonary Edema Prognostic Score (PEPS) | Fiutowski | 2008 | Chronic Heart Failure (CHF) | Mortality | 0 |
05-035-01 | Prytherch 2005 - IIB + Elective AAA Repair, Mortality | Prytherch | 2005 | Aortic Disease | Mortality | 2 |
05-035-02 | Prytherch 2005 - IIB + Elective AAA Repair, Morbidity | Prytherch | 2005 | Aortic Disease | MACCE+ | 1 |
05-035-03 | Prytherch 2005 - Emergency AAA Repair, Mortality | Prytherch | 2005 | Aortic Disease | Mortality | 1 |
05-035-04 | Prytherch 2005 - Emergency AAA Repair, Morbidity | Prytherch | 2005 | Aortic Disease | MACCE+ | 1 |
14-055-01 | Prosthetic valve, Age, Large intracardiac destruction, Staphylococcus spp, Urgent surgery, Sex, EuroSCORE (PALSUSE) Score | Martinez-Selles | 2014 | Cardiac Surgery | Mortality | 0 |
07-019-01 | Prosser 2007 | Prosser | 2007 | Stroke | MACE | 0 |
02-001-01 | Prospective Cardiovascular Münster (PROCAM) | Assmann | 2002 | Population Sample | MACE | 6 |
13-084-01 | Priority of surgery, Peripheral arteriopathy, Preoperative cardiac failure and/or LVEF < 40%, Chronic kidney failure and/or preoperative creatininemia >2 mg/dl (PACK2) Score | Hornero | 2013 | Coronary Artery Disease (CAD) | Stroke | 0 |
13-084-02 | Priority of surgery, Peripheral arteriopathy, Preoperative cardiac failure and/or LVEF < 40%, Chronic kidney failure and/or preoperative creatininemia >2 mg/dl (PACK2) Decision Tree | Hornero | 2013 | Coronary Artery Disease (CAD) | Stroke | 0 |
04-004-01 | Primary Angioplasty in Myocardial Infarction (PAMI) Score | Addala | 2004 | Coronary Artery Disease (CAD) | Mortality | 4 |
13-062-01 | Preventive Antibacterial Therapy in Acute Ischaemic Stroke (PANTHERIS) Score | Harms | 2013 | Stroke | Pneumonia | 0 |
12-079-01 | Prevention of Diabetes Complications in People With Hyperglycaemia in Europe (PREDICE) Score | de la Camara | 2012 | Chronic Heart Failure (CHF) | Mortality | 0 |
15-003-01 | prestroke Independence [modified Rankin scale], Sex, Age, National Institutes ofHealth Stroke Scale (ISAN) Score | Smith | 2015 | Stroke | Pneumonia | 3 |
14-038-01 | Prediction Rule for Endocarditis in Injection Drug Users (PRE-IDU) Instrument | Chung-Esaki | 2014 | Population Sample | Endocarditis | 0 |
99-009-03 | Predicting Risk of Death in Cardiac Disease Tool (PREDICT) - 6 Years | Jacobs | 1999 | Coronary Artery Disease (CAD) | Mortality | 1 |
99-009-01 | Predicting Risk of Death in Cardiac Disease Tool (PREDICT) - 30 Days | Jacobs | 1999 | Coronary Artery Disease (CAD) | Mortality | 1 |
99-009-02 | Predicting Risk of Death in Cardiac Disease Tool (PREDICT) - 2 Years | Jacobs | 1999 | Coronary Artery Disease (CAD) | Mortality | 1 |
14-019-01 | PREdict asymptomatic CORonary artery disease in patients with ISchemic stroke and TIA (PRECORIS) Score | Calvet | 2014 | Stroke | Coronary Artery Disease (CAD) | 1 |
12-085-03 | Preadmission comorbidities, Level of consciousness, Age, and Neurologic deficit (PLAN) Score - Poor Prognosis | O'Donnell | 2012 | Stroke | Functional Outcome | 2 |
12-085-01 | Preadmission comorbidities, Level of consciousness, Age, and Neurologic deficit (PLAN) Score - 30 Day Mortality | O'Donnell | 2012 | Stroke | Mortality | 3 |
12-085-02 | Preadmission comorbidities, Level of consciousness, Age, and Neurologic deficit (PLAN) Score - 1 Year Mortality | O'Donnell | 2012 | Stroke | Mortality | 2 |
89-001-01 | Pre-Arrest Morbidity (PAM) Score | George | 1989 | Cardiac Arrest | Mortality | 1 |
14-046-05 | Postoperative Atrial Fibrillation (POAF) Score - Renal Replacement Therapy | Mariscalco | 2014 | Cardiac Surgery | Renal Outcomes | 0 |
14-046-01 | Postoperative Atrial Fibrillation (POAF) Score - Postoperative AF | Mariscalco | 2014 | Cardiac Surgery | Arrhythmia | 0 |
14-046-02 | Postoperative Atrial Fibrillation (POAF) Score - Hospital Mortality | Mariscalco | 2014 | Cardiac Surgery | Mortality | 0 |
14-046-03 | Postoperative Atrial Fibrillation (POAF) Score - Cerebrovascular Accident | Mariscalco | 2014 | Cardiac Surgery | Stroke | 0 |
14-046-04 | Postoperative Atrial Fibrillation (POAF) Score - Acute Kidney Injury | Mariscalco | 2014 | Cardiac Surgery | Renal Outcomes | 0 |
13-101-01 | Post-Stroke Depression Prediction Scale | de Man-van Ginkel | 2013 | Stroke | Depression | 0 |
15-002-01 | porcelain Thoracic aorta, Anemia, left Ventricular dysfunction, recent myocardial Infarction,male Sex category,Critical aortic valve stenosis,Old age, and Renal dysfunction (TAVI2-SCORe) | Debonnaire | 2015 | Valve Disease | Mortality | 1 |
98-006-01 | Polanczyk 1998 | Polanczyk | 1998 | Chronic Heart Failure (CHF) | Mortality | 1 |
12-060-01 | Podolecki 2012 | Podolecki | 2012 | Coronary Artery Disease (CAD) | Stroke | 0 |
06-043-01 | Pneumonia Score | Kwon | 2006 | Stroke | Pneumonia | 4 |
00-010-01 | Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin (eptifibatide) Therapy (PURSUIT) - Mortality | Boersma | 2000 | Coronary Artery Disease (CAD) | Mortality | 3 |
00-010-02 | Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin (eptifibatide) Therapy (PURSUIT) - MACE | Boersma | 2000 | Coronary Artery Disease (CAD) | MACE | 4 |
12-011-01 | Placebo-Controlled Randomized Study of the Selective A1-Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) | O'Connor | 2012 | Chronic Heart Failure (CHF) | Chronic Heart Failure (CHF) | 1 |
14-058-01 | Pittsburgh Outcomes After Stroke Thrombectomy (POST) Score | Rangaraju | 2014 | Stroke | Functional Outcome | 2 |
03-017-01 | Piombo 2003 | Piombo | 2003 | Coronary Artery Disease (CAD) | MACE | 0 |
99-003-01 | Philbin 1999 | Philbin | 1999 | Chronic Heart Failure (CHF) | Chronic Heart Failure (CHF) | 0 |
13-019-01 | Pfister 2013 | Pfister | 2013 | Coronary Artery Disease (CAD) | Chronic Heart Failure (CHF) | 0 |
07-012-02 | Personal Heart Early Assessment Risk Tool (HEART) score - Women | Mainous | 2007 | Population Sample | MACE | 0 |
07-012-01 | Personal Heart Early Assessment Risk Tool (HEART) score - Men | Mainous | 2007 | Population Sample | MACE | 0 |
14-021-01 | Perry 2014 | Perry | 2014 | Stroke | Stroke | 0 |
08-019-01 | Percutaneous Coronary Intervention - Thrombolytic Predictive Instrument (PCI-TPI) | Kent | 2008 | Coronary Artery Disease (CAD) | Mortality | 1 |
13-083-01 | Percutaneous Cardiopulmonary Support (PCPS) Survival Score | Shirakabe | 2013 | Miscellaneous | Mortality | 0 |
13-038-01 | Pennekamp 2013 | Pennekamp | 2013 | Carotid Disease | Shunt for Cerebral Perfusion | 0 |
12-015-01 | Payabvash 2012 - Right Arm | Payabvash | 2012 | Stroke | Functional Outcome | 0 |
12-015-03 | Payabvash 2012 - Left Leg | Payabvash | 2012 | Stroke | Functional Outcome | 0 |
12-015-02 | Payabvash 2012 - Left Arm | Payabvash | 2012 | Stroke | Functional Outcome | 0 |
05-008-01 | Passman 2005 | Passman | 2005 | Cancer | Arrhythmia | 0 |
89-002-01 | Parsonnet Score | Parsonnet | 1989 | Cardiac Surgery | Mortality | 25 |
06-008-01 | Parkash 2006 | Parkash | 2006 | Arrhythmia | Mortality | 0 |
12-018-01 | Park 2012 | Park | 2012 | Coronary Artery Disease (CAD) | Stroke | 0 |
11-058-01 | Papworth Bleeding Risk Score | Vuylsteke | 2011 | Cardiac Surgery | Hemorrhage | 1 |
13-012-01 | Papaioannou 2013 | Papaioannou | 2013 | Venous Thromboembolism (VTE) | Mortality | 0 |
14-016-01 | Pannucci 2014 | Pannucci | 2014 | Post-Operative | Venous Thromboembolism (VTE) | 0 |
12-017-01 | Pannucci 2012 | Pannucci | 2012 | Post-Operative | Venous Thromboembolism (VTE) | 0 |
12-059-01 | Pannucci 2012 | Pannucci | 2012 | Population Sample | Venous Thromboembolism (VTE) | 0 |
10-061-01 | Padua Prediction Score | Barbar | 2010 | Population Sample | Venous Thromboembolism (VTE) | 1 |
13-026-01 | Owolabi 2013 | Owolabi | 2013 | Stroke | Stroke | 0 |
98-005-01 | Outpatient Bleeding Risk Index (OBRI) - 3 Months | Beyth | 1998 | Population Sample | Hemorrhage | 3 |
98-005-02 | Outpatient Bleeding Risk Index (OBRI) - 12 Months | Beyth | 1998 | Population Sample | Hemorrhage | 6 |
06-033-01 | Out-of-Hospital Cardiac Arrest (OHCA) Score | Adrie | 2006 | Cardiac Arrest | MANE | 3 |
05-034-01 | Oudega Deep Venous Thrombosis (DVT) Rule | Oudega | 2005 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 0 |
13-077-01 | Ottawa Heart Failure Risk Scale | Stiell | 2013 | Chronic Heart Failure (CHF) | MACE+ | 0 |
09-005-01 | Oto 2009 | Oto | 2009 | Stroke | Functional Outcome | 0 |
10-009-01 | Ostman-Smith 2010 | Ostman-Smith | 2010 | Congenital Heart Disease | Mortality | 0 |
03-009-01 | Osservatorio Epidemiologico sulla Sincope nel Lazio (OSEIL) Risk Score | Colivicchi | 2003 | Syncope | Mortality | 3 |
14-066-02 | Open-Heart Intraoperative Risk (OHIR) Score - Logistic Regression Equation | Tribuddharat | 2014 | Cardiac Surgery | Prolonged LOS | 1 |
14-054-01 | Open-Heart Intraoperative Risk (OHIR) Score | Tribuddharat | 2014 | Cardiac Surgery | Prolonged LOS | 1 |
95-009-01 | Ontario Province Risk (OPR) Score | Tu | 1995 | Cardiac Surgery | Composite | 16 |
13-092-01 | Ong 2013 | Ong | 2013 | Chest Pain | Composite | 0 |
03-013-01 | One-Year Mortality (OYM) Model | Wang | 2003 | Stroke | Mortality | 2 |
12-055-02 | Onat 2012 - Women | Onat | 2012 | Population Sample | Coronary Artery Disease (CAD) | 0 |
12-055-01 | Onat 2012 - Men | Onat | 2012 | Population Sample | Coronary Artery Disease (CAD) | 0 |
14-061-01 | Oldenbeuving 2014 | Oldenbeuving | 2014 | Stroke | Delirium | 1 |
07-028-01 | Okamoto 2007 | Okamoto | 2007 | Population Sample | Stroke | 0 |
12-072-01 | Okada 2012 | Okada | 2012 | Cardiac Arrest | Functional Outcome | 0 |
13-054-01 | Ogata 2013 | Ogata | 2013 | Population Sample | Mortality | 0 |
14-010-01 | Observational Study Of Appropriateness, Efficacy And
Effectiveness of AVR-TAVR Procedures For the Treatment Of Severe Symptomatic Aortic Stenosis (OBSERVANT) Score | Capodanno | 2014 | Valve Disease | Mortality | 3 |
12-064-02 | O'Connor 2012 - Mortality | O'Connor | 2012 | Chronic Heart Failure (CHF) | Mortality | 0 |
12-064-01 | O'Connor 2012 - Hospitalization/Mortality | O'Connor | 2012 | Chronic Heart Failure (CHF) | Composite | 0 |
08-010-01 | O'Connor 2008 | O'Connor | 2008 | Chronic Heart Failure (CHF) | Mortality | 2 |
97-005-02 | O'Connor 1997 - PE or Death | O'Connor | 1997 | Coronary Artery Disease (CAD) | MACE | 0 |
97-005-03 | O'Connor 1997 - Death | O'Connor | 1997 | Coronary Artery Disease (CAD) | Mortality | 0 |
97-005-01 | O'Connor 1997 - CHF/PE or Worse | O'Connor | 1997 | Coronary Artery Disease (CAD) | MACE | 0 |
92-008-01 | O'Connor 1992 | O'Connor | 1992 | Coronary Artery Disease (CAD) | Mortality | 3 |
13-053-02 | NYC Risk Score - Valve/CABG | Hannan | 2013 | Cardiac Surgery | Mortality | 3 |
13-053-01 | NYC Risk Score - Valve | Hannan | 2013 | Valve Disease | Mortality | 3 |
10-046-01 | Novack 2010 - 30 Days | Novack | 2010 | Chronic Heart Failure (CHF) | Mortality | 0 |
10-046-02 | Novack 2010 - 1 Year | Novack | 2010 | Chronic Heart Failure (CHF) | Mortality | 0 |
03-015-01 | Northern New England Cardiovascular Disease Study Group (NNECDSG) Risk Score | Charlesworth | 2003 | Coronary Artery Disease (CAD) | Stroke | 1 |
05-016-01 | Northern New England (NNE) Unified Model | Jin | 2005 | Cardiac Surgery | Mortality | 1 |
99-013-01 | Northern New England (NNE) Model | O'Connor | 1999 | Coronary Artery Disease (CAD) | Mortality | 3 |
04-008-02 | Northern New England (NNE) for Mitral Valve Repair/Replacement (MVRR) | Nowicki | 2004 | Cardiac Surgery | Mortality | 2 |
04-008-01 | Northern New England (NNE) for Aortic Valve Repair (AVR) | Nowicki | 2004 | Cardiac Surgery | Mortality | 3 |
07-006-01 | North West Quality Improvement Programme in Cardiac Interventions (NWQIP) Score | Kuduvalli | 2007 | Cardiac Surgery | Mortality | 2 |
06-001-01 | North West Quality Improvement Programme in Cardiac Interventions (NWQIP) Model | Grayson | 2006 | Coronary Artery Disease (CAD) | MACCE | 1 |
12-086-01 | North American Chest Pain Rule | Hess | 2012 | Chest Pain | MACE | 1 |
96-003-01 | Normand 1996 | Normand | 1996 | Coronary Artery Disease (CAD) | Mortality | 2 |
10-021-03 | Noda 2010 - Weighted Multiplicative Model | Noda | 2010 | Population Sample | MACE | 0 |
10-021-02 | Noda 2010 - Weighted Additive Model | Noda | 2010 | Population Sample | MACE | 0 |
10-021-01 | Noda 2010 - Unweighted Additive Model | Noda | 2010 | Population Sample | MACE | 0 |
93-001-03 | Niskanen 1993 - Model C (Preoperative, Operative, and Postoperative) | Niskanen | 1993 | Stroke | Functional Outcome | 0 |
93-001-02 | Niskanen 1993 - Model B (Preoperative and Operative) | Niskanen | 1993 | Stroke | Functional Outcome | 0 |
93-001-01 | Niskanen 1993 - Model A (Preoperative) | Niskanen | 1993 | Stroke | Functional Outcome | 0 |
08-002-01 | Nishiuchi 2008 | Nishiuchi | 2008 | Cardiac Arrest | Mortality | 0 |
06-047-04 | NIPPONDATA80 Risk Assesment Chart (ND80RAC) - Stroke in Women | NIPPON DATA80 Research Group | 2006 | Population Sample | Mortality | 1 |
06-047-03 | NIPPONDATA80 Risk Assesment Chart (ND80RAC) - Stroke in Men | NIPPON DATA80 Research Group | 2006 | Population Sample | Mortality | 1 |
06-047-06 | NIPPONDATA80 Risk Assesment Chart (ND80RAC) - CVD in Women | NIPPON DATA80 Research Group | 2006 | Population Sample | Mortality | 0 |
06-047-05 | NIPPONDATA80 Risk Assesment Chart (ND80RAC) - CVD in Men | NIPPON DATA80 Research Group | 2006 | Population Sample | Mortality | 0 |
06-047-02 | NIPPONDATA80 Risk Assesment Chart (ND80RAC) - CHD in Women | NIPPON DATA80 Research Group | 2006 | Population Sample | Mortality | 1 |
06-047-01 | NIPPONDATA80 Risk Assesment Chart (ND80RAC) - CHD in Men | NIPPON DATA80 Research Group | 2006 | Population Sample | Mortality | 1 |
07-033-02 | Nikolsky 2007 - Clinical Variables Only | Nikolsky | 2007 | Coronary Artery Disease (CAD) | Hemorrhage | 5 |
07-033-01 | Nikolsky 2007 - Clinical and Procedural Variables | Nikolsky | 2007 | Coronary Artery Disease (CAD) | Hemorrhage | 0 |
07-030-01 | Nielsen 2007 | Nielsen | 2007 | Population Sample | Composite | 0 |
09-033-01 | Ngako 2009 - Clinical Model | Ngako | 2009 | Chest Pain | MACE | 0 |
09-033-03 | Ngako 2009 - Clinical + ECG + cTnI | Ngako | 2009 | Chest Pain | MACE | 0 |
09-033-02 | Ngako 2009 - Clinical + ECG | Ngako | 2009 | Chest Pain | MACE | 0 |
10-059-04 | New Zealand Diabetes Cohort Study - First MI, Including Antihypertensive Meds | Elley | 2010 | Population Sample | Coronary Artery Disease (CAD) | 0 |
10-059-03 | New Zealand Diabetes Cohort Study - First MI | Elley | 2010 | Population Sample | Coronary Artery Disease (CAD) | 0 |
10-059-02 | New Zealand Diabetes Cohort Study - CVD, Including Antihypertensive Meds | Elley | 2010 | Population Sample | MACE | 4 |
10-059-01 | New Zealand Diabetes Cohort Study - CVD | Elley | 2010 | Population Sample | MACE | 4 |
13-096-01 | New York State PCI Risk Score | Hannan | 2013 | Coronary Artery Disease (CAD) | Mortality | 1 |
97-016-02 | New York State (NYS) Model - Unplanned CABG | Hannan | 1997 | Cardiac Surgery | Revascularization | 0 |
97-016-01 | New York State (NYS) Model - Mortality | Hannan | 1997 | Cardiac Surgery | Mortality | 3 |
13-015-01 | New York CABG Risk Score | Hannan | 2013 | Coronary Artery Disease (CAD) | Mortality | 1 |
06-009-01 | New York (NY) Score | Wu | 2006 | Coronary Artery Disease (CAD) | Mortality | 2 |
10-040-01 | New Risk Stratification (NERS) Score | Chen | 2010 | Coronary Artery Disease (CAD) | MACE | 0 |
03-031-02 | New intracerebral hemorrhage (ICH) Score | Cheung | 2003 | Stroke | Mortality | 2 |
09-012-01 | Negassa 2009 | Negassa | 2009 | Coronary Artery Disease (CAD) | Composite | 1 |
07-022-01 | Negassa 2007 | Negassa | 2007 | Coronary Artery Disease (CAD) | Mortality | 1 |
13-070-01 | Naya 2013 | Naya | 2013 | Chest Pain | MACE | 0 |
08-036-01 | National Institutes ofHealth Stroke Scale (NIHSS)/age model - functional outcome | Konig | 2008 | Stroke | Functional Outcome | 2 |
04-001-02 | National Institutes of Health Stroke Scale (NIHSS)+Age - Mortality | Weimar | 2004 | Stroke | Mortality | 2 |
04-001-01 | National Institutes of Health Stroke Scale (NIHSS)+Age - Functional Outcome | Weimar | 2004 | Stroke | Functional Outcome | 3 |
08-036-02 | National Institutes of Health Stroke Scale (NIHSS)/age model - survival | Konig | 2008 | Stroke | Mortality | 2 |
91-007-04 | National Institute for Health and Clinical Excellence (NICE) Framingham - SBP, Stroke | Anderson | 1991 | Population Sample | Stroke | 1 |
91-007-02 | National Institute for Health and Clinical Excellence (NICE) Framingham - SBP, MI | Anderson | 1991 | Population Sample | Myocardial Infarction (MI) | 1 |
91-007-06 | National Institute for Health and Clinical Excellence (NICE) Framingham - SBP, CVD Death | Anderson | 1991 | Population Sample | Mortality | 2 |
91-007-05 | National Institute for Health and Clinical Excellence (NICE) Framingham - SBP, CVD | Anderson | 1991 | Population Sample | MACCE | 19 |
91-007-03 | National Institute for Health and Clinical Excellence (NICE) Framingham - SBP, CHD Death | Anderson | 1991 | Population Sample | Mortality | 0 |
91-007-01 | National Institute for Health and Clinical Excellence (NICE) Framingham - SBP, CHD | Anderson | 1991 | Population Sample | MACE | 6 |
91-007-10 | National Institute for Health and Clinical Excellence (NICE) Framingham - DBP, Stroke | Anderson | 1991 | Population Sample | Stroke | 0 |
91-007-08 | National Institute for Health and Clinical Excellence (NICE) Framingham - DBP, MI | Anderson | 1991 | Population Sample | Myocardial Infarction (MI) | 0 |
91-007-12 | National Institute for Health and Clinical Excellence (NICE) Framingham - DBP, CVD Death | Anderson | 1991 | Population Sample | Mortality | 0 |
91-007-11 | National Institute for Health and Clinical Excellence (NICE) Framingham - DBP, CVD | Anderson | 1991 | Population Sample | MACCE | 0 |
91-007-09 | National Institute for Health and Clinical Excellence (NICE) Framingham - DBP, CHD Death | Anderson | 1991 | Population Sample | Mortality | 0 |
91-007-07 | National Institute for Health and Clinical Excellence (NICE) Framingham - DBP, CHD | Anderson | 1991 | Population Sample | MACE | 1 |
12-042-01 | National Cardiovascular Data Registry Carotid Artery Stenting (NCDR CAS) Score - In Hospital | Hawkins | 2012 | Carotid Disease | MANE | 0 |
12-042-02 | National Cardiovascular Data Registry Carotid Artery Stenting (NCDR CAS) Score - 30 Days | Hawkins | 2012 | Carotid Disease | MANE | 0 |
10-030-01 | National Cardiovascular Data Registry (NCDR) Risk Model | Peterson | 2010 | Coronary Artery Disease (CAD) | Mortality | 3 |
12-063-01 | Nakajima 2012 | Nakajima | 2012 | Chest Pain | MACE | 0 |
08-052-01 | Myers 2008 - Mortality | Myers | 2008 | Chronic Heart Failure (CHF) | Mortality | 0 |
08-052-02 | Myers 2008 - Composite Endpoint | Myers | 2008 | Chronic Heart Failure (CHF) | MACE | 0 |
14-045-01 | Murthy 2014 | Murthy | 2014 | Stroke | Mortality | 0 |
08-032-01 | Munich Score | Stempfle | 2008 | Chronic Heart Failure (CHF) | Composite | 0 |
08-045-01 | Multicentre Stroke Survey (MSS) Score - Symptomatic ICH | Cucchiara | 2008 | Stroke | Stroke | 6 |
08-045-03 | Multicentre Stroke Survey (MSS) Score - Parenchymal Hemorrhage | Cucchiara | 2008 | Stroke | Stroke | 0 |
08-045-02 | Multicentre Stroke Survey (MSS) Score - Asymptomatic ICH | Cucchiara | 2008 | Stroke | Stroke | 1 |
96-007-01 | Multicenter Study of Perioperative Ischemia (McSPT) Risk Score | Newman | 1996 | Coronary Artery Disease (CAD) | MANE | 2 |
13-080-01 | Mrdovic 2013 | Mrdovic | 2013 | Coronary Artery Disease (CAD) | Hemorrhage | 1 |
13-020-01 | Mrdovic 2013 | Mrdovic | 2013 | Coronary Artery Disease (CAD) | MACCE | 0 |
02-017-02 | Morise 2002 - MVD | Morise | 2002 | Coronary Artery Disease (CAD) | Coronary Artery Disease (CAD) | 0 |
02-017-01 | Morise 2002 - CAD | Morise | 2002 | Coronary Artery Disease (CAD) | Coronary Artery Disease (CAD) | 1 |
97-007-01 | Morise 1997 | Morise | 1997 | Coronary Artery Disease (CAD) | Coronary Artery Disease (CAD) | 5 |
92-015-01 | Morise 1992 - Pretest | Morise | 1992 | Coronary Artery Disease (CAD) | Coronary Artery Disease (CAD) | 1 |
92-015-03 | Morise 1992 - Postthallium Test | Morise | 1992 | Coronary Artery Disease (CAD) | Coronary Artery Disease (CAD) | 1 |
92-015-02 | Morise 1992 - Postexercise EKG | Morise | 1992 | Coronary Artery Disease (CAD) | Coronary Artery Disease (CAD) | 2 |
09-027-01 | Monin 2009 | Monin | 2009 | Valve Disease | Composite | 1 |
08-047-01 | Modified Wells Rule | Gibson | 2008 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 0 |
08-037-01 | Modified Thrombolysis in Myocardial Infarction (TIMI) Risk Score | Garcia-Almagro | 2008 | Chest Pain | MACE | 0 |
16-002-01 | Modified Stroke subtype, Oxfordshire Community Stroke Project classification, Age, and prestroke
modified Rankin (mSOAR) Score | Abdul-Rahim | 2016 | Stroke | Mortality | 1 |
03-031-01 | Modified intracerebral hemorrhage (ICH) Score | Cheung | 2003 | Stroke | Mortality | 4 |
06-044-02 | Modified Intracerebral Haemorrhage (ICH) Score B (mICH-B) | Godoy | 2006 | Stroke | Mortality | 4 |
06-044-01 | Modified Intracerebral Haemorrhage (ICH) Score A (mICH-A) | Godoy | 2006 | Stroke | Mortality | 4 |
09-025-01 | Modified EuroSCORE | Nissinen | 2009 | Cardiac Surgery | Mortality | 0 |
08-050-01 | Modified Congestive Heart Failure,Hypertension, Age, Diabetes mellitus, and prior Stroke or TIA (CHADS2) | Rietbrock | 2008 | Arrhythmia | Stroke | 1 |
08-017-01 | Mocan 2008 | Mocan | 2008 | Population Sample | Myocardial Infarction (MI) | 0 |
08-034-01 | Miura 2008 | Miura | 2008 | Chronic Heart Failure (CHF) | Mortality | 0 |
08-039-01 | Miniati 2008 | Miniati | 2008 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 1 |
03-004-01 | Miniati 2003 | Miniati | 2003 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 0 |
09-026-01 | Michaelides 2009 | Michaelides | 2009 | Coronary Artery Disease (CAD) | MACE | 0 |
10-042-01 | Miceli 2010 | Miceli | 2010 | Coronary Artery Disease (CAD) | IABP Placement | 0 |
13-094-01 | Mets 2013 | Mets | 2013 | Population Sample | Composite | 1 |
13-004-01 | Metabolic Exercise Cardiac Kidney Indexes (MECKI) | Agostoni | 2013 | Chronic Heart Failure (CHF) | Composite | 1 |
13-006-02 | Meta Analyses Global Group in Chronic Heart Failure (MAGGIC) risk score - 3 Years | Pocock | 2013 | Chronic Heart Failure (CHF) | Mortality | 1 |
13-006-01 | Meta Analyses Global Group in Chronic Heart Failure (MAGGIC) risk score - 1 Year | Pocock | 2013 | Chronic Heart Failure (CHF) | Mortality | 0 |
04-023-01 | Merle 2004 | Merle | 2004 | Peripheral Vascular Disease (PVD) | Mortality | 0 |
09-048-01 | Mehta 2009 | Mehta | 2009 | Coronary Artery Disease (CAD) | Reoperation for Bleeding | 0 |
08-030-01 | Mehta 2008 | Mehta | 2008 | Coronary Artery Disease (CAD) | Mortality | 0 |
11-026-01 | Mehran 2011 | Mehran | 2011 | Coronary Artery Disease (CAD) | Hemorrhage | 0 |
95-003-01 | Mehra 1995 | Mehra | 1995 | Heart Transplant | Graft Vasculopathy | 0 |
06-017-02 | McGuirk 2006 - Model 2 | McGuirk | 2006 | Cardiac Surgery | Mortality | 0 |
06-017-01 | McGuirk 2006 - Model 1 | McGuirk | 2006 | Cardiac Surgery | Mortality | 0 |
11-052-03 | McGorrian 2011 - Non-Laboratory Modifiable Risk Score | McGorrian | 2011 | Population Sample | Myocardial Infarction (MI) | 0 |
11-052-01 | McGorrian 2011 - INTERHEART Modifiable Risk Score | McGorrian | 2011 | Population Sample | Myocardial Infarction (MI) | 1 |
11-052-02 | McGorrian 2011 - Full INTERHEART Modifiable Risk Score | McGorrian | 2011 | Population Sample | Myocardial Infarction (MI) | 1 |
11-052-04 | McGorrian 2011 - Cholesterol Modifiable Risk Score | McGorrian | 2011 | Population Sample | Myocardial Infarction (MI) | 0 |
07-010-01 | McDonald 2007 | McDonald | 2007 | Chest Pain | MACE | 0 |
09-021-01 | Mazza 2009 | Mazza | 2009 | Arrhythmia | Arrhythmia | 0 |
03-008-01 | Mazur 2003 | Mazur | 2003 | Coronary Artery Disease (CAD) | MACE | 0 |
07-018-01 | Mayo Clinic Risk Score (MCRS) - Post-PCI Procedural Death | Singh | 2007 | Coronary Artery Disease (CAD) | Mortality | 1 |
07-018-02 | Mayo Clinic Risk Score (MCRS) - Post-PCI In-Hospital MACE | Singh | 2007 | Coronary Artery Disease (CAD) | MACCE | 0 |
02-011-01 | Mayo Clinic Risk Score (MCRS) | Singh | 2002 | Coronary Artery Disease (CAD) | MACCE | 3 |
13-046-01 | Matsuo 2013 | Matsuo | 2013 | Cancer | Venous Thromboembolism (VTE) | 0 |
04-005-02 | Mathew 2004 - Recurrent AF | Mathew | 2004 | Coronary Artery Disease (CAD) | Arrhythmia | 0 |
04-005-01 | Mathew 2004 - Postop AF | Mathew | 2004 | Coronary Artery Disease (CAD) | Arrhythmia | 0 |
11-015-01 | Mashour 2011 | Mashour | 2011 | Post-Operative | Stroke | 0 |
95-005-01 | Mase 1995 | Mase | 1995 | Stroke | Mortality | 2 |
04-009-01 | Marwick 2004 | Marwick | 2004 | Chest Pain | MACE | 1 |
91-002-01 | Marwick 1991 - Onset of Resuscitation | Marwick | 1991 | Cardiac Arrest | Mortality | 0 |
91-002-03 | Marwick 1991 - After Survival from Resuscitation | Marwick | 1991 | Cardiac Arrest | Mortality | 0 |
91-002-02 | Marwick 1991 - After 10 Min of Resuscitation | Marwick | 1991 | Cardiac Arrest | Mortality | 0 |
06-022-01 | Martins 2006 | Martins | 2006 | Population Sample | Mortality | 0 |
10-007-01 | Martinez-Selles 2010 | Martinez-Selles | 2010 | Chronic Heart Failure (CHF) | Mortality | 0 |
14-050-01 | MARseilles-Nimes (MARNI) Score | Cohen | 2014 | Miscellaneous | Venous Thromboembolism (VTE) | 0 |
01-027-01 | Marschner 2001 | Marschner | 2001 | Coronary Artery Disease (CAD) | Coronary Artery Disease (CAD) | 2 |
91-011-01 | Mark 1991 - Late Complications | Mark | 1991 | Coronary Artery Disease (CAD) | MACE | 0 |
91-011-02 | Mark 1991 - Death/Reinfarction at 30 Days | Mark | 1991 | Coronary Artery Disease (CAD) | MACE | 0 |
91-008-01 | Marik 1991 | Marik | 1991 | Coronary Artery Disease (CAD) | Mortality | 1 |
08-015-01 | Maracy 2008 | Maracy | 2008 | Population Sample | Coronary Artery Disease (CAD) | 0 |
08-009-01 | Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese(MEGA) Score | Teramoto | 2008 | Population Sample | MACE | 0 |
10-044-01 | Maluenda 2010 | Maluenda | 2010 | Coronary Artery Disease (CAD) | Mortality | 0 |
96-005-01 | Magovern 1996 | Magovern | 1996 | Coronary Artery Disease (CAD) | Composite | 4 |
13-111-01 | Magnetic Resonance Imaging-Dense cerebral artery sign/early infarct signs on admission CT scan, prestroke modified Rankin Scale (mRS) score, Age, Glucose level at baseline, Onset-to-treatment time, and baseline National Institutes of Health Stroke Scale score (MRI-DRAGON) | Turc | 2013 | Stroke | Functional Outcome | 1 |
09-047-03 | Losartan Intervention For Endpoint (LIFE) Risk Score - Stroke | Kjeldsen | 2009 | Population Sample | Stroke | 0 |
09-047-02 | Losartan Intervention For Endpoint (LIFE) Risk Score - Mortality | Kjeldsen | 2009 | Population Sample | Mortality | 0 |
09-047-04 | Losartan Intervention For Endpoint (LIFE) Risk Score - MI | Kjeldsen | 2009 | Population Sample | Myocardial Infarction (MI) | 0 |
09-047-01 | Losartan Intervention For Endpoint (LIFE) Risk Score - MACCE | Kjeldsen | 2009 | Population Sample | MACCE | 0 |
07-031-01 | Long-Term Survival Score (LTSS) | Landesberg | 2007 | Cardiac Surgery | Mortality | 1 |
97-017-01 | Long Beach and Palo Alto (LP-BA) Equation - Pre-Exercise Test | Do | 1997 | Coronary Artery Disease (CAD) | Coronary Artery Disease (CAD) | 0 |
97-017-02 | Long Beach and Palo Alto (LP-BA) Equation - Post-Exercise Test | Do | 1997 | Coronary Artery Disease (CAD) | Coronary Artery Disease (CAD) | 1 |
03-029-01 | Logistic EuroSCORE | Roques | 2003 | Cardiac Surgery | Mortality | 94 |
12-046-02 | Logistic Clinical Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Score - Extended Model | Farooq | 2012 | Coronary Artery Disease (CAD) | Mortality | 1 |
12-046-01 | Logistic Clinical Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Score - Core Model | Farooq | 2012 | Coronary Artery Disease (CAD) | Mortality | 5 |
13-048-01 | Lo 2013 | Lo | 2013 | Coronary Artery Disease (CAD) | Coronary Artery Disease (CAD) | 0 |
14-044-01 | Liu 2014 | Liu | 2014 | Stroke | Venous Thromboembolism (VTE) | 0 |
13-034-01 | Liu 2013 | Liu | 2013 | Coronary Artery Disease (CAD) | MACE | 0 |
12-045-01 | Liu 2012 | Liu | 2012 | Pregnancy | Composite | 0 |
04-010-04 | Liu 2004 - Women, Framingham | Liu | 2004 | Population Sample | MACE | 0 |
04-010-03 | Liu 2004 - Women, CMCS | Liu | 2004 | Population Sample | MACE | 0 |
04-010-02 | Liu 2004 - Men, Framingham | Liu | 2004 | Population Sample | MACE | 0 |
04-010-01 | Liu 2004 - Men, CMCS | Liu | 2004 | Population Sample | MACE | 0 |
94-005-02 | Lisk 1994 - Poor Outcome | Lisk | 1994 | Stroke | Functional Outcome | 1 |
94-005-01 | Lisk 1994 - Independent Outcome | Lisk | 1994 | Stroke | Functional Outcome | 0 |
01-026-01 | Lin 2001 | Lin | 2001 | Valve Disease | Coronary Artery Disease (CAD) | 2 |
03-012-01 | Lim 2003 | Lim | 2003 | Cardiac Surgery | Coronary Artery Disease (CAD) | 2 |
03-014-01 | Likosky 2003 | Likosky | 2003 | Coronary Artery Disease (CAD) | Stroke | 0 |
07-021-01 | Lietz 2007 | Lietz | 2007 | Chronic Heart Failure (CHF) | Mortality | 0 |
05-028-01 | Liang 2005 | Liang | 2005 | Chronic Heart Failure (CHF) | Chronic Heart Failure (CHF) | 0 |
13-030-01 | Li 2013 | Li | 2013 | Aortic Disease | Procedural Complications | 0 |
09-038-01 | Lewis 2009 | Lewis | 2009 | Coronary Artery Disease (CAD) | Chronic Heart Failure (CHF) | 0 |
02-005-01 | Lewis 2002 | Lewis | 2002 | Population Sample | Mortality | 1 |
01-005-01 | LeMaire 2001 | LeMaire | 2001 | Aortic Disease | Composite | 0 |
95-011-01 | Leiden Score | Steyerberg | 1995 | Aortic Disease | Mortality | 2 |
09-054-01 | Lei 2009 | Lei | 2009 | Cardiac Surgery | Prolonged LOS | 0 |
12-022-01 | Lee 2012 | Lee | 2012 | Chronic Heart Failure (CHF) | Mortality | 0 |
95-010-01 | Lee 1995 | Lee | 1995 | Coronary Artery Disease (CAD) | Mortality | 1 |
11-062-02 | Landseed ICH (LSICH) Score - Unfavorable Outcome | Chen | 2011 | Stroke | Functional Outcome | 0 |
11-062-01 | Landseed ICH (LSICH) Score - Mortality | Chen | 2011 | Stroke | Mortality | 1 |
09-009-01 | Laboratory Index (LI) | Giraldez | 2009 | Coronary Artery Disease (CAD) | Mortality | 1 |
96-002-02 | L'Italien 1996 - Dipyridamole Thallium Variables | L'Italien | 1996 | Peripheral Vascular Disease (PVD) | MACE | 0 |
96-002-01 | L'Italien 1996 - Clinical Variables | L'Italien | 1996 | Peripheral Vascular Disease (PVD) | MACE | 0 |
12-077-01 | Ky 2012 | Ky | 2012 | Chronic Heart Failure (CHF) | Composite | 0 |
01-017-01 | Kumar 2001 | Kumar | 2001 | Coronary Artery Disease (CAD) | MACE | 0 |
99-001-01 | Kuijer 1999 | Kuijer | 1999 | Venous Thromboembolism (VTE) | Hemorrhage | 5 |
01-024-01 | Kuhan 2001 | Kuhan | 2001 | Carotid Disease | MANE | 0 |
05-005-01 | Kucher 2005 | Kucher | 2005 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 1 |
01-014-01 | Krumholz 2001 | Krumholz | 2001 | Coronary Artery Disease (CAD) | Mortality | 0 |
00-001-02 | Krumholz 2000 - HF Readmission | Krumholz | 2000 | Chronic Heart Failure (CHF) | Chronic Heart Failure (CHF) | 1 |
00-001-03 | Krumholz 2000 - All Cause Readmission or Death | Krumholz | 2000 | Chronic Heart Failure (CHF) | Composite | 1 |
00-001-01 | Krumholz 2000 - All Cause Readmission | Krumholz | 2000 | Chronic Heart Failure (CHF) | Hospitalization | 1 |
99-006-01 | Krumholz 1999 | Krumholz | 1999 | Coronary Artery Disease (CAD) | Mortality | 0 |
14-024-01 | Kretz 2014 | Kretz | 2014 | Carotid Disease | Shunt for Cerebral Perfusion | 0 |
12-058-01 | Kramer 2012 | Kramer | 2012 | Chronic Heart Failure (CHF) | Mortality | 0 |
14-012-01 | Kraaier 2014 | Kraaier | 2014 | Chronic Heart Failure (CHF) | Mortality | 1 |
12-062-01 | Koyak 2012 | Koyak | 2012 | Congenital Heart Disease | ICD Shocks | 0 |
05-010-01 | Kostrubiec 2005 | Kostrubiec | 2005 | Venous Thromboembolism (VTE) | Mortality | 0 |
13-002-01 | Koster 2013 | Koster | 2013 | Cardiac Surgery | Delirium | 0 |
12-014-01 | Kostalova 2012 - First Model | Kostalova | 2012 | Stroke | Delirium | 0 |
12-014-02 | Kostalova 2012 - Alternative Model | Kostalova | 2012 | Stroke | Delirium | 0 |
11-055-01 | Korea Acute Myocardial Infarction Registry-1 (KAMIR-1) Score | Kim | 2011 | Coronary Artery Disease (CAD) | Mortality | 1 |
03-003-01 | Koplan 2003 | Koplan | 2003 | Cardiac Surgery | Pacemaker Placement | 0 |
09-001-01 | Koopman 2009 | Koopman | 2009 | Stroke | Functional Outcome | 0 |
97-013-02 | Knuiman 1997 - Women, Without BMI | Knuiman | 1997 | Population Sample | Mortality | 0 |
97-013-04 | Knuiman 1997 - Women, With BMI | Knuiman | 1997 | Population Sample | Mortality | 0 |
97-013-01 | Knuiman 1997 - Men, Without BMI | Knuiman | 1997 | Population Sample | Mortality | 1 |
97-013-03 | Knuiman 1997 - Men, With BMI | Knuiman | 1997 | Population Sample | Mortality | 0 |
10-006-01 | Klotz 2010 | Klotz | 2010 | Chronic Heart Failure (CHF) | Mortality | 0 |
02-016-01 | Kline 2002 | Kline | 2002 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 1 |
09-039-01 | Kinugasa 2009 | Kinugasa | 2009 | Chronic Heart Failure (CHF) | Mortality | 0 |
95-002-01 | Kimmel 1995 | Kimmel | 1995 | Coronary Artery Disease (CAD) | MACE | 1 |
14-036-01 | Kim 2014 | Kim | 2014 | Stroke | Renal Outcomes | 0 |
12-048-01 | Kim 2012 | Kim | 2012 | Stroke | Stroke | 0 |
11-040-01 | Kim 2011 | Kim | 2011 | Coronary Artery Disease (CAD) | MACE | 0 |
11-003-01 | Kim 2011 | Kim | 2011 | Aortic Disease | Procedural Complications | 0 |
10-032-05 | Kim 2010 - traditional risk factor (TRF) model, women with CVD history excluded | Kim | 2010 | Population Sample | MACE | 0 |
10-032-02 | Kim 2010 - traditional risk factor (TRF) model, all eligible women included | Kim | 2010 | Population Sample | MACE | 0 |
10-032-04 | Kim 2010 - Framingham risk score with new coefficients (FRSN) model, women with CVD history excluded | Kim | 2010 | Population Sample | MACE | 0 |
10-032-01 | Kim 2010 - Framingham risk score with new coefficients (FRSN) model, all eligible women included | Kim | 2010 | Population Sample | MACE | 0 |
10-032-06 | Kim 2010 - additional biomarker (ABM) model, women with CVD history excluded | Kim | 2010 | Population Sample | MACE | 0 |
10-032-03 | Kim 2010 - additional biomarker (ABM) model, all eligible women included | Kim | 2010 | Population Sample | MACE | 0 |
10-002-01 | Kim 2010 | Kim | 2010 | Coronary Artery Disease (CAD) | Mortality | 0 |
06-015-01 | Kim 2006 | Kim | 2006 | Cancer | Mortality | 0 |
08-028-01 | Khorana 2008 | Khorana | 2008 | Cancer | Venous Thromboembolism (VTE) | 3 |
15-007-01 | Khazanie 2015 | Khazanie | 2015 | Chronic Heart Failure (CHF) | Mortality | 1 |
06-041-01 | Khairy 2006 | Khairy | 2006 | Congenital Heart Disease | MACE | 1 |
90-002-01 | Kentsch 1990 | Kentsch | 1990 | Cardiac Arrest | Mortality | 0 |
08-020-01 | Keenan 2008 | Keenan | 2008 | Chronic Heart Failure (CHF) | Hospitalization | 0 |
03-016-01 | Kearney 2003 | Kearney | 2003 | Chronic Heart Failure (CHF) | Mortality | 0 |
13-099-01 | Kay 2013 | Kay | 2013 | Chest Pain | Mortality | 0 |
13-105-01 | Kawaguchi 2013 | Kawaguchi | 2013 | Cancer | Venous Thromboembolism (VTE) | 0 |
10-052-01 | Kasim 2010 | Kasim | 2010 | Stroke | Functional Outcome | 0 |
97-001-06 | Karlson 1997 - New ED Admission at 365 Days | Karlson | 1997 | Chest Pain | Hospitalization | 0 |
97-001-04 | Karlson 1997 - New ED Admission at 30 Days | Karlson | 1997 | Chest Pain | Hospitalization | 0 |
97-001-05 | Karlson 1997 - New ED Admission at 183 Days | Karlson | 1997 | Chest Pain | Hospitalization | 0 |
97-001-03 | Karlson 1997 - Cardiac Death at 365 Days | Karlson | 1997 | Chest Pain | Mortality | 0 |
97-001-01 | Karlson 1997 - Cardiac Death at 30 Days | Karlson | 1997 | Chest Pain | Mortality | 0 |
97-001-02 | Karlson 1997 - Cardiac Death at 183 Days | Karlson | 1997 | Chest Pain | Mortality | 0 |
99-007-04 | Kannel 1999 - Women, Model 2 | Kannel | 1999 | Population Sample | Chronic Heart Failure (CHF) | 0 |
99-007-03 | Kannel 1999 - Women, Model 1 | Kannel | 1999 | Population Sample | Chronic Heart Failure (CHF) | 0 |
99-007-02 | Kannel 1999 - Men, Model 2 | Kannel | 1999 | Population Sample | Chronic Heart Failure (CHF) | 2 |
99-007-01 | Kannel 1999 - Men, Model 1 | Kannel | 1999 | Population Sample | Chronic Heart Failure (CHF) | 0 |
12-001-01 | Kang 2012 | Kang | 2012 | Population Sample | MACCE | 0 |
12-051-01 | Kamouchi 2012 - Overall Population | Kamouchi | 2012 | Stroke | Stroke | 0 |
12-051-02 | Kamouchi 2012 - Noncardioembolic Subpopulation | Kamouchi | 2012 | Stroke | Stroke | 0 |
93-004-01 | Kalra 1993 | Kalra | 1993 | Peripheral Vascular Disease (PVD) | Myocardial Infarction (MI) | 0 |
12-076-01 | Kalogeropoulos 2012 | Kalogeropoulos | 2012 | Population Sample | Chronic Heart Failure (CHF) | 0 |
99-002-01 | Kahn 1999 | Kahn | 1999 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 2 |
14-004-02 | Jorgensen 2014 - Fatal or Nonfatal CVD | Jorgensen | 2014 | Population Sample | Composite | 0 |
14-004-01 | Jorgensen 2014 - Fatal CVD | Jorgensen | 2014 | Population Sample | Mortality | 0 |
10-034-01 | Jons 2010 | Jons | 2010 | Coronary Artery Disease (CAD) | Arrhythmia | 0 |
00-003-04 | Johnston 2000 - Very Poor Outcome (NIHSS) | Johnston | 2000 | Stroke | Functional Outcome | 0 |
00-003-06 | Johnston 2000 - Very Poor Outcome (GOS) | Johnston | 2000 | Stroke | Functional Outcome | 0 |
00-003-05 | Johnston 2000 - Very Poor Outcome (BI) | Johnston | 2000 | Stroke | Functional Outcome | 0 |
00-003-01 | Johnston 2000 - Excellent Outcome (NIHSS) | Johnston | 2000 | Stroke | Functional Outcome | 0 |
00-003-03 | Johnston 2000 - Excellent Outcome (GOS) | Johnston | 2000 | Stroke | Functional Outcome | 0 |
00-003-02 | Johnston 2000 - Excellent Outcome (BI) | Johnston | 2000 | Stroke | Functional Outcome | 0 |
00-002-01 | John 2000 | John | 2000 | Coronary Artery Disease (CAD) | Stroke | 0 |
92-006-01 | Jivegard 1992 | Jivegard | 1992 | Peripheral Vascular Disease (PVD) | Mortality | 0 |
12-068-01 | Jensen 2012 | Jensen | 2012 | Chest Pain | Coronary Artery Disease (CAD) | 0 |
08-022-02 | Jee 2008 - Women | Jee | 2008 | Population Sample | Stroke | 0 |
08-022-01 | Jee 2008 - Men | Jee | 2008 | Population Sample | Stroke | 0 |
13-027-01 | Japanese Coronary Spasm Association (JCSA) Risk Score | Takagi | 2013 | Chest Pain | MACE | 0 |
10-060-01 | Japan Arteriosclerosis Longitudinal Study Existing Cohorts Combine (JALS-ECC)- Non-HDL-C Model | Tanabe | 2010 | Population Sample | Coronary Artery Disease (CAD) | 1 |
10-060-02 | Japan Arteriosclerosis Longitudinal Study Existing Cohorts Combine (JALS-ECC) - TC Model | Tanabe | 2010 | Population Sample | Coronary Artery Disease (CAD) | 1 |
14-056-02 | Jairam 2014 - 3 Years | Jairam | 2014 | Population Sample | MACCE | 0 |
14-056-01 | Jairam 2014 - 1 Year | Jairam | 2014 | Population Sample | MACCE | 1 |
14-051-01 | Iung 2014 | Iung | 2014 | Valve Disease | Mortality | 1 |
96-006-01 | Iung 1996 | Iung | 1996 | Cardiac Surgery | Technical Success | 0 |
11-005-01 | Ito 2011 | Ito | 2011 | Coronary Artery Disease (CAD) | MACCE | 0 |
14-037-02 | Italian Project on Stroke in Young Adults (IPSYS) Score - 5 Years | Pezzini | 2014 | Stroke | MACCE | 0 |
14-037-01 | Italian Project on Stroke in Young Adults (IPSYS) Score - 1 Year | Pezzini | 2014 | Stroke | MACCE | 0 |
16-003-01 | Israeli TAVR Registry Risk Model Accuracy Assessment (IRRMA) Model | Halkin | 2016 | Valve Disease | Mortality | 0 |
13-042-01 | Ishikawa 2013 | Ishikawa | 2013 | Cardiac Arrest | Mortality | 0 |
11-056-01 | iScore - 30 Days | Saposnik | 2011 | Stroke | Mortality | 17 |
11-056-02 | iScore - 1 Year | Saposnik | 2011 | Stroke | Mortality | 6 |
11-047-01 | Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE) - Primary Composite | Komajda | 2011 | Chronic Heart Failure (CHF) | MACCE | 0 |
11-047-03 | Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE) - HF Composite | Komajda | 2011 | Chronic Heart Failure (CHF) | MACCE | 0 |
11-047-02 | Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE) - All-Cause Mortality | Komajda | 2011 | Chronic Heart Failure (CHF) | MACCE | 0 |
14-003-02 | Iosifescu 2014 - Postoperative Complications | Iosifescu | 2014 | Cardiac Surgery | Procedural Complications | 0 |
14-003-01 | Iosifescu 2014 - In Hospital Mortality | Iosifescu | 2014 | Cardiac Surgery | Mortality | 0 |
10-063-02 | Intraventricular Hemorrhage (IVH) Score - Unfavorable Outcome | Stein | 2010 | Stroke | Functional Outcome | 1 |
10-063-01 | Intraventricular Hemorrhage (IVH) Score - Mortality | Stein | 2010 | Stroke | Mortality | 1 |
14-059-02 | Intracerebral HemorrhageAssociated Pneumonia Score (ICH-APS)-B | Ji | 2014 | Stroke | Pneumonia | 0 |
14-059-01 | Intracerebral HemorrhageAssociated Pneumonia Score (ICH-APS)-A | Ji | 2014 | Stroke | Pneumonia | 0 |
07-009-01 | Intracerebral Hemorrhage Grading Scale (ICH-GS) - In-Hospital Mortality | Ruiz-Sandoval | 2007 | Stroke | Mortality | 4 |
07-009-02 | Intracerebral Hemorrhage Grading Scale (ICH-GS) - 30-Day Mortality | Ruiz-Sandoval | 2007 | Stroke | Mortality | 1 |
07-009-03 | Intracerebral Hemorrhage Grading Scale (ICH-GS) - 30-Day Good Outcome | Ruiz-Sandoval | 2007 | Stroke | Functional Outcome | 0 |
01-003-01 | Intracerebral hemorrhage (ICH) Score | Hemphill | 2001 | Stroke | Mortality | 27 |
08-023-01 | Intracerebral Haemorrhage Outcome Score (ICHOS) | Huang | 2008 | Stroke | Mortality | 1 |
13-029-01 | INternational VErapamil-SR/Trandolapril STudy (INVEST) Risk Score - Primary Outcome | Bavry | 2013 | Coronary Artery Disease (CAD) | MACCE | 0 |
13-029-06 | INternational VErapamil-SR/Trandolapril STudy (INVEST) Risk Score - Nonfatal Stroke | Bavry | 2013 | Coronary Artery Disease (CAD) | Stroke | 0 |
13-029-05 | INternational VErapamil-SR/Trandolapril STudy (INVEST) Risk Score - Nonfatal MI | Bavry | 2013 | Coronary Artery Disease (CAD) | Myocardial Infarction (MI) | 0 |
13-029-04 | INternational VErapamil-SR/Trandolapril STudy (INVEST) Risk Score - Non-CV Mortality | Bavry | 2013 | Coronary Artery Disease (CAD) | Mortality | 0 |
13-029-03 | INternational VErapamil-SR/Trandolapril STudy (INVEST) Risk Score - CV Mortality | Bavry | 2013 | Coronary Artery Disease (CAD) | Mortality | 0 |
13-029-02 | INternational VErapamil-SR/Trandolapril STudy (INVEST) Risk Score - All Cause Mortality | Bavry | 2013 | Coronary Artery Disease (CAD) | Mortality | 0 |
10-017-01 | International Subarachnoid Aneurysm Trial (ISAT) Model | Risselada | 2010 | Stroke | Mortality | 2 |
07-002-01 | International Registry of Acute Aortic Dissection (IRAD) Score - Pre-Operative Variables | Rampoldi | 2007 | Aortic Disease | Mortality | 1 |
07-002-02 | International Registry of Acute Aortic Dissection (IRAD) Score - All Variables | Rampoldi | 2007 | Aortic Disease | Mortality | 0 |
11-013-02 | International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)- Associative Model | Spyropoulos | 2011 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 1 |
11-013-01 | International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) - Predictive Model | Spyropoulos | 2011 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 0 |
15-004-01 | International Heart Transplant Survival Algorithm (IHTSA) | Nilsson | 2015 | Heart Transplant | Mortality | 2 |
13-079-01 | InsCor | Mejia | 2013 | Cardiac Surgery | Mortality | 0 |
01-009-01 | Individual Data Analysis of Antihypertensive Intervention (INDIANA) - Women | Pocock | 2001 | Population Sample | Mortality | 4 |
01-009-02 | Individual Data Analysis of Antihypertensive Intervention (INDIANA) - Men | Pocock | 2001 | Population Sample | Mortality | 0 |
11-019-02 | Implantable Cardioverter-Defibrillator (ICD)-RSAO - In-Hospital Mortality | Haines | 2011 | Chronic Heart Failure (CHF) | Mortality | 0 |
11-019-01 | Implantable Cardioverter-Defibrillator (ICD)-RSAO - Any Complication | Haines | 2011 | Chronic Heart Failure (CHF) | Composite | 0 |
12-025-01 | Iida 2012 | Iida | 2012 | Peripheral Vascular Disease (PVD) | Mortality | 0 |
11-041-01 | Iida 2011 | Iida | 2011 | Peripheral Vascular Disease (PVD) | Stent Patency | 0 |
12-023-01 | ICH Index (ICHI) | Li | 2012 | Stroke | Mortality | 1 |
13-087-01 | Iannuzzi 2013 | Iannuzzi | 2013 | Post-Operative | Venous Thromboembolism (VTE) | 0 |
10-018-01 | Hypertension, Age, Transient ischemic attack or stroke, Chronic obstructive pulmonary disease and Heart failure (HATCH) Score | de Vos | 2010 | Arrhythmia | Arrhythmia | 2 |
10-025-01 | Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile international normalized ratio, Elderly, Drugs/alcohol concomitantly (HAS-BLED) | Pisters | 2010 | Arrhythmia | Hemorrhage | 24 |
08-040-01 | Huynh 2008 | Huynh | 2008 | Chronic Heart Failure (CHF) | Mortality | 0 |
06-029-01 | Huynh 2006 | Huynh | 2006 | Chronic Heart Failure (CHF) | Mortality | 0 |
14-040-01 | Hull Cardiopulmonary Exercise Testing (CPET) Risk Score | Ingle | 2014 | Chronic Heart Failure (CHF) | Mortality | 0 |
13-025-01 | Hubert 2013 | Hubert | 2013 | Endocarditis | Composite | 0 |
92-013-01 | Hubbard 1992 | Hubbard | 1992 | Coronary Artery Disease (CAD) | Coronary Artery Disease (CAD) | 0 |
13-041-01 | Hu 2013 | Hu | 2013 | Coronary Artery Disease (CAD) | Mortality | 0 |
14-060-01 | Hsu 2014 | Hsu | 2014 | Chronic Heart Failure (CHF) | Inadequate DSM | 0 |
13-028-02 | Houston Intra-Arterial Therapy 2 (HIAT2) + Imaging | Sarraj | 2013 | Stroke | Functional Outcome | 3 |
13-028-01 | Houston Intra-Arterial Therapy 2 (HIAT2) | Sarraj | 2013 | Stroke | Functional Outcome | 6 |
09-017-01 | Houston Intra-Arterial recanalization Therapy (HIAT) Score | Hallevi | 2009 | Stroke | Functional Outcome | 11 |
08-048-01 | Hong Kong Diabetes Register (HKDR) Risk Score | Yang | 2008 | Population Sample | Coronary Artery Disease (CAD) | 3 |
11-061-01 | Hong 2011 | Hong | 2011 | Heart Transplant | Graft Failure | 0 |
12-065-01 | Holme 2012 | Holme | 2012 | Valve Disease | Mortality | 0 |
12-080-02 | Hoke 2012 - Cardiovascular Mortality | Hoke | 2012 | Carotid Disease | Mortality | 1 |
12-080-01 | Hoke 2012 - All-Cause Mortality | Hoke | 2012 | Carotid Disease | Mortality | 1 |
06-028-01 | Hofmann 2006 | Hofmann | 2006 | Carotid Disease | MACCE | 0 |
08-044-01 | History, ECG, Age, Risk factors and Troponin (HEART) Score | Six | 2008 | Chest Pain | MACE | 6 |
11-031-05 | Hippisley-Cox 2011 - 5 Years | Hippisley-Cox | 2011 | Population Sample | Venous Thromboembolism (VTE) | 2 |
11-031-04 | Hippisley-Cox 2011 - 4 Years | Hippisley-Cox | 2011 | Population Sample | Venous Thromboembolism (VTE) | 0 |
11-031-03 | Hippisley-Cox 2011 - 3 Years | Hippisley-Cox | 2011 | Population Sample | Venous Thromboembolism (VTE) | 0 |
11-031-02 | Hippisley-Cox 2011 - 2 Years | Hippisley-Cox | 2011 | Population Sample | Venous Thromboembolism (VTE) | 0 |
11-031-01 | Hippisley-Cox 2011 - 1 Year | Hippisley-Cox | 2011 | Population Sample | Venous Thromboembolism (VTE) | 0 |
02-012-04 | Hintze 2002 - Model 4 | Hintze | 2002 | Coronary Artery Disease (CAD) | Mortality | 0 |
02-012-03 | Hintze 2002 - Model 3 | Hintze | 2002 | Coronary Artery Disease (CAD) | Mortality | 0 |
02-012-02 | Hintze 2002 - Model 2 | Hintze | 2002 | Coronary Artery Disease (CAD) | Mortality | 0 |
02-012-01 | Hintze 2002 - Model 1 | Hintze | 2002 | Coronary Artery Disease (CAD) | Mortality | 0 |
97-010-04 | Higgins 1997 - Preoperative Severity Score | Higgins | 1997 | Coronary Artery Disease (CAD) | MACCE+ | 0 |
97-010-03 | Higgins 1997 - ICU Risk Stratification Score | Higgins | 1997 | Coronary Artery Disease (CAD) | MACCE+ | 2 |
97-010-01 | Higgins 1997 - Admission Mortality | Higgins | 1997 | Coronary Artery Disease (CAD) | Mortality | 2 |
97-010-02 | Higgins 1997 - Admission Morbidity | Higgins | 1997 | Coronary Artery Disease (CAD) | MACCE+ | 1 |
05-026-02 | Heywood 2005 - 5 Years | Heywood | 2005 | Chronic Heart Failure (CHF) | Mortality | 0 |
05-026-01 | Heywood 2005 - 1 Year | Heywood | 2005 | Chronic Heart Failure (CHF) | Mortality | 0 |
13-024-01 | Herman 2013 | Herman | 2013 | Cardiac Surgery | Composite | 0 |
09-031-01 | Herman 2009 | Herman | 2009 | Coronary Artery Disease (CAD) | Prolonged LOS | 0 |
06-013-01 | Hepatic or renal disease, Ethanol abuse, Malignancy, Older (age N 75 years), Reduced platelet count or function, hypertension, Anemia, Genetic factors, Excessive fall risk, and Stroke (HEMORR2HAGES) | Gage | 2006 | Arrhythmia | Hemorrhage | 8 |
08-011-01 | Hemorrhage After Thrombolysis (HAT) Score | Lou | 2008 | Stroke | Stroke | 11 |
94-003-01 | Hemodynamic Risk Score (HRS) | Morley | 1994 | Chronic Heart Failure (CHF) | Mortality | 0 |
14-026-02 | Hematoma Expansion (HE) Prediction Score - In Hospital Mortality | Brouwers | 2014 | Stroke | Mortality | 0 |
14-026-01 | Hematoma Expansion (HE) Prediction Score - Expansion | Brouwers | 2014 | Stroke | Hematoma Expansion | 2 |
14-026-03 | Hematoma Expansion (HE) Prediction Score - 3 Month Mortality | Brouwers | 2014 | Stroke | Mortality | 0 |
13-047-01 | HeartMate Risk Score (HMRS) - 90 Days | Cowger | 2013 | Chronic Heart Failure (CHF) | Mortality | 3 |
13-047-03 | HeartMate Risk Score (HMRS) - 2 Years | Cowger | 2013 | Chronic Heart Failure (CHF) | Mortality | 1 |
13-047-02 | HeartMate Risk Score (HMRS) - 1 Year | Cowger | 2013 | Chronic Heart Failure (CHF) | Mortality | 1 |
97-003-01 | Heart Failure Survival Score (HFSS) - Noninvasive Model | Aaronson | 1997 | Chronic Heart Failure (CHF) | Mortality | 8 |
97-003-02 | Heart Failure Survival Score (HFSS) - Invasive Model | Aaronson | 1997 | Chronic Heart Failure (CHF) | Mortality | 2 |
09-016-01 | Heart Failure Index | Stevens | 2009 | Coronary Artery Disease (CAD) | Chronic Heart Failure (CHF) | 0 |
06-048-01 | Heart Failure (HF) Revised Score | Rohde | 2006 | Chronic Heart Failure (CHF) | Mortality | 0 |
08-018-01 | Health Aging and Body Composition (ABC) Heart Failure (HF) | Butler | 2008 | Population Sample | Chronic Heart Failure (CHF) | 1 |
11-016-01 | Hayakawa 2011 - VF | Hayakawa | 2011 | Cardiac Arrest | Functional Outcome | 1 |
11-016-02 | Hayakawa 2011 - PEA/Asystole | Hayakawa | 2011 | Cardiac Arrest | Functional Outcome | 1 |
04-019-03 | Haukoos 2004 - Survival with GCS >= 14 | Haukoos | 2004 | Cardiac Arrest | Functional Outcome | 0 |
04-019-02 | Haukoos 2004 - Survival with GCS >= 13 | Haukoos | 2004 | Cardiac Arrest | Functional Outcome | 0 |
04-019-04 | Haukoos 2004 - Survival with GCS = 15 | Haukoos | 2004 | Cardiac Arrest | Functional Outcome | 0 |
04-019-01 | Haukoos 2004 - Survival to Hospital Discharge | Haukoos | 2004 | Cardiac Arrest | Mortality | 0 |
96-001-01 | Hardman Index | Hardman | 1996 | Aortic Disease | Mortality | 7 |
07-008-02 | Hannan 2007 - Valve/CABG | Hannan | 2007 | Cardiac Surgery | Mortality | 2 |
07-008-01 | Hannan 2007 - Isolated Valve | Hannan | 2007 | Cardiac Surgery | Mortality | 3 |
06-010-01 | Hannan 2006 | Hannan | 2006 | Coronary Artery Disease (CAD) | Mortality | 0 |
94-006-01 | Hannan 1994 | Hannan | 1994 | Cardiac Surgery | Mortality | 4 |
92-002-02 | Hannan 1992 - Major Complication | Hannan | 1992 | Coronary Artery Disease (CAD) | MACE | 0 |
92-002-01 | Hannan 1992 - In Hospital Death | Hannan | 1992 | Coronary Artery Disease (CAD) | Mortality | 1 |
92-002-03 | Hannan 1992 - Absence of Angiographic Success | Hannan | 1992 | Coronary Artery Disease (CAD) | Technical Success | 0 |
92-004-02 | Hankey 1992 - Stroke, MI, or Vascular Death at 5 Years | Hankey | 1992 | Stroke | MACCE | 0 |
92-004-01 | Hankey 1992 - Stroke, MI, or Vascular Death at 1 Year | Hankey | 1992 | Stroke | MACCE | 2 |
92-004-04 | Hankey 1992 - Stroke at 5 Years | Hankey | 1992 | Stroke | Stroke | 0 |
92-004-03 | Hankey 1992 - Stroke at 1 Year | Hankey | 1992 | Stroke | Stroke | 2 |
92-004-06 | Hankey 1992 - Coronary Event at 5 Years | Hankey | 1992 | Stroke | MACE | 0 |
92-004-05 | Hankey 1992 - Coronary Event at 1 Year | Hankey | 1992 | Stroke | MACE | 0 |
02-014-01 | Hallevy intracerebral hemorrhage (ICH) Score | Hallevy | 2002 | Stroke | Functional Outcome | 0 |
02-015-01 | Hakala 2002 | Hakala | 2002 | Coronary Artery Disease (CAD) | Arrhythmia | 1 |
92-010-04 | Hadorn 1992 - Tree 4 | Hadorn | 1992 | Coronary Artery Disease (CAD) | Mortality | 0 |
92-010-03 | Hadorn 1992 - Tree 3 | Hadorn | 1992 | Coronary Artery Disease (CAD) | Mortality | 0 |
92-010-02 | Hadorn 1992 - Tree 2 | Hadorn | 1992 | Coronary Artery Disease (CAD) | Mortality | 0 |
92-010-01 | Hadorn 1992 - Tree 1 | Hadorn | 1992 | Coronary Artery Disease (CAD) | Mortality | 0 |
05-004-02 | Hachamovitch 2005 - Simplified Prognostic Score | Hachamovitch | 2005 | Coronary Artery Disease (CAD) | Mortality | 0 |
05-004-01 | Hachamovitch 2005 - Overall Score | Hachamovitch | 2005 | Coronary Artery Disease (CAD) | Mortality | 0 |
99-017-01 | Habil 1999 | Habil | 1999 | Population Sample | Coronary Artery Disease (CAD) | 0 |
13-010-01 | Gupta 2013 | Gupta | 2013 | Carotid Disease | MACCE | 0 |
12-021-01 | Gupta 2012 | Gupta | 2012 | Peripheral Vascular Disease (PVD) | Mortality | 0 |
11-028-01 | Gupta 2011 | Gupta | 2011 | Post-Operative | MACE | 1 |
10-008-02 | Guo 2010 - Mitral | Guo | 2010 | Valve Disease | Mortality | 0 |
10-008-03 | Guo 2010 - Combined Aortic/Mitral | Guo | 2010 | Valve Disease | Mortality | 0 |
10-008-01 | Guo 2010 - Aortic | Guo | 2010 | Valve Disease | Mortality | 0 |
14-018-01 | Guijarro 2014 - VTE | Guijarro | 2014 | Population Sample | Venous Thromboembolism (VTE) | 0 |
14-018-02 | Guijarro 2014 - Bleeding | Guijarro | 2014 | Population Sample | Hemorrhage | 0 |
10-029-01 | GuaragnaSCORE | Guaragna | 2010 | Cardiac Surgery | Mortality | 2 |
00-018-01 | Grzybowski 2000 | Grzybowski | 2000 | Chest Pain | Mortality | 0 |
96-004-01 | Grzybowski 1996 | Grzybowski | 1996 | Chronic Heart Failure (CHF) | Composite | 1 |
01-020-01 | Gruppo Italiano per lo Studio della Sopravvivenza nellInfarto miocardico (GISSI) Prevenzione Risk Function - Women | Marchioli | 2001 | Coronary Artery Disease (CAD) | Mortality | 0 |
01-020-02 | Gruppo Italiano per lo Studio della Sopravvivenza nellInfarto miocardico (GISSI) Prevenzione Risk Function - Men | Marchioli | 2001 | Coronary Artery Disease (CAD) | Mortality | 0 |
03-006-01 | Gruppo Italiano per lo Studio della Sopravvivenza nellInfarto (GISSI)-2 | Villella | 2003 | Coronary Artery Disease (CAD) | Mortality | 1 |
12-007-01 | Greving 2012 | Greving | 2012 | Stroke | Functional Outcome | 0 |
13-049-02 | Greco 2013 - Simplified Score | Greco | 2013 | Population Sample | Coronary Artery Disease (CAD) | 0 |
13-049-01 | Greco 2013 - Full Risk Model and Score | Greco | 2013 | Population Sample | Coronary Artery Disease (CAD) | 0 |
06-036-01 | Grave Prognosis on Spontaneous Intracerebral Haemorrhage (GP on STAGE) Score | Poungvarin | 2006 | Stroke | Functional Outcome | 1 |
13-051-01 | Grant 2013 | Grant | 2013 | Aortic Disease | Mortality | 0 |
12-067-01 | Grant 2012 | Grant | 2012 | Aortic Disease | Renal Outcomes | 0 |
06-004-04 | Gottschall 2006 - Model 4 | Gottschall | 2006 | Coronary Artery Disease (CAD) | Revascularization | 0 |
06-004-03 | Gottschall 2006 - Model 3 | Gottschall | 2006 | Coronary Artery Disease (CAD) | Revascularization | 0 |
06-004-02 | Gottschall 2006 - Model 2 | Gottschall | 2006 | Coronary Artery Disease (CAD) | Revascularization | 0 |
06-004-01 | Gottschall 2006 - Model 1 | Gottschall | 2006 | Coronary Artery Disease (CAD) | Revascularization | 0 |
98-007-01 | Gordon 1998 | Gordon | 1998 | Cardiac Surgery | Pacemaker Placement | 1 |
12-029-02 | Goliasch 2012 - Simplified Score Without Cholinesterase | Goliasch | 2012 | Coronary Artery Disease (CAD) | Mortality | 0 |
12-029-01 | Goliasch 2012 - Simplified Score | Goliasch | 2012 | Coronary Artery Disease (CAD) | Mortality | 1 |
96-010-01 | Goldman Rule | Goldman | 1996 | Chest Pain | Composite | 4 |
08-026-01 | Goldenberg 2008 | Goldenberg | 2008 | Chronic Heart Failure (CHF) | Mortality | 0 |
12-032-01 | Glucose at presentation, Race, Age, Sex, systolic blood Pressure at presentation, and Severity of stroke at presentation
(NIHSS) (GRASPS) | Menon | 2012 | Stroke | Stroke | 5 |
09-045-01 | Global Vascular Risk Score (GVRS) | Sacco | 2009 | Population Sample | MACCE | 0 |
10-014-01 | Global Risk Classification (GRC) | Capodanno | 2010 | Coronary Artery Disease (CAD) | Mortality | 2 |
03-023-01 | Global Registry of Acute Coronary Events (GRACE) | Granger | 2003 | Coronary Artery Disease (CAD) | Mortality | 53 |
94-002-01 | Glasgow Aneurysm Score (GAS) | Samy | 1994 | Aortic Disease | Mortality | 20 |
09-008-01 | Giles Risk Score | Giles | 2009 | Aortic Disease | Mortality | 3 |
13-072-01 | Get With The GuidelinesStroke (GWTG-Stroke) - Model Without NIHSS | Smith | 2013 | Stroke | Mortality | 0 |
13-072-02 | Get With The GuidelinesStroke (GWTG-Stroke) - Model With NIHSS | Smith | 2013 | Stroke | Mortality | 1 |
10-047-02 | Get With the GuidelinesStroke (GWTG-Stroke) - Model with NIHSS | Smith | 2010 | Stroke | Mortality | 1 |
10-047-01 | Get With the GuidelinesStroke (GWTG-Stroke) - Model w/o NIHSS | Smith | 2010 | Stroke | Mortality | 0 |
14-041-01 | German Coronary Artery Bypass Grafting (CABG) Score | Kotting | 2014 | Coronary Artery Disease (CAD) | Mortality | 1 |
13-018-01 | German Aortic Valve Score | Kotting | 2013 | Cardiac Surgery | Mortality | 4 |
00-016-01 | Geneva Risk Score | Wicki | 2000 | Venous Thromboembolism (VTE) | Composite | 3 |
10-013-01 | Gencer 2010 | Gencer | 2010 | Chest Pain | Coronary Artery Disease (CAD) | 1 |
10-064-01 | Gastrointestinal Complication Score (GICS) | Andersson | 2010 | Cardiac Surgery | To be updated | 1 |
09-018-01 | Garcia-Alvarez 2009 | Garcia-Alvarez | 2009 | Coronary Artery Disease (CAD) | Composite | 0 |
04-021-01 | Garcia 2004 | Garcia | 2004 | Coronary Artery Disease (CAD) | Revascularization | 0 |
11-017-01 | Gan 2011 | Gan | 2011 | Population Sample | Stroke | 0 |
08-016-01 | Gabriel 2008 | Gabriel | 2008 | Aortic Disease | Technical Success | 0 |
07-013-01 | Fuwai Score - Logistic | Xu | 2007 | Cardiac Surgery | Prolonged LOS | 1 |
07-013-02 | Fuwai Score - Additive | Xu | 2007 | Cardiac Surgery | Prolonged LOS | 0 |
08-043-01 | Functional Outcome in Intracerebral hemorrhage (FUNC) | Rost | 2008 | Stroke | Functional Outcome | 2 |
13-069-01 | Fujii 2013 | Fujii | 2013 | Stroke | Arrhythmia | 0 |
13-013-01 | Fu 2013 | Fu | 2013 | Coronary Artery Disease (CAD) | CIN | 0 |
12-061-01 | Frontal QRS-T AngleAge Risk (FAAR) Score | Lown | 2012 | Coronary Artery Disease (CAD) | Mortality | 1 |
06-046-01 | Front Door Score | Conway Morris | 2006 | Chest Pain | MACE | 1 |
95-001-01 | French Score - Mortality | Roques | 1995 | Cardiac Surgery | Mortality | 4 |
95-001-02 | French Score - Morbidity | Roques | 1995 | Cardiac Surgery | MACE | 2 |
10-053-01 | Fremantle Diabetes Study | Davis | 2010 | Population Sample | MACE | 5 |
09-050-01 | Freedom-from-Events (FFE) Risk Score | Brieger | 2009 | Coronary Artery Disease (CAD) | MACE | 2 |
00-021-05 | Framingham-Subsequent CHD - Women | D'Agostino | 2000 | Cardiovascular Disease (CVD) | Coronary Artery Disease (CAD) | 0 |
00-021-04 | Framingham-Subsequent CHD - Men | D'Agostino | 2000 | Cardiovascular Disease (CVD) | Coronary Artery Disease (CAD) | 1 |
00-021-02 | Framingham-Initial CHD - Women, Without Triglycerides | D'Agostino | 2000 | Population Sample | Coronary Artery Disease (CAD) | 0 |
00-021-03 | Framingham-Initial CHD - Women, With Triglycerides | D'Agostino | 2000 | Population Sample | Coronary Artery Disease (CAD) | 0 |
00-021-01 | Framingham-Initial CHD - Men | D'Agostino | 2000 | Population Sample | Coronary Artery Disease (CAD) | 0 |
94-004-02 | Framingham Risk Score (FRS)-Stroke - Women | D'Agostino | 1994 | Population Sample | Stroke | 2 |
94-004-01 | Framingham Risk Score (FRS)-Stroke - Men | D'Agostino | 1994 | Population Sample | Stroke | 7 |
97-019-01 | Framingham Risk Score (FRS) Claudication | Murabito | 1997 | Population Sample | Intermittent Claudication | 1 |
98-002-02 | Framingham for Women 1998 | Wilson | 1998 | Population Sample | MACE | 13 |
08-027-01 | Framingham for Women | D'Agostino | 2008 | Population Sample | MACCE | 7 |
91-010-02 | Framingham for Stroke - Women | Wolf | 1991 | Population Sample | Stroke | 2 |
03-018-02 | Framingham for Stroke - Stroke or Death | Wang | 2003 | Arrhythmia | MANE | 1 |
03-018-01 | Framingham for Stroke - Stroke | Wang | 2003 | Arrhythmia | Stroke | 5 |
91-010-01 | Framingham for Stroke - Men | Wolf | 1991 | Population Sample | Stroke | 3 |
98-002-01 | Framingham for Men 1998 | Wilson | 1998 | Population Sample | MACE | 35 |
08-027-02 | Framingham for Men | D'Agostino | 2008 | Population Sample | MACCE | 13 |
09-010-01 | Framingham for AF | Schnabel | 2009 | Population Sample | Arrhythmia | 8 |
06-031-06 | Fox Global Registry of Acute Coronary Events (GRACE) - Discharge; Death or MI at 6 Months | Fox | 2006 | Coronary Artery Disease (CAD) | Mortality | 2 |
06-031-05 | Fox Global Registry of Acute Coronary Events (GRACE) - Discharge; Death at 6 Months | Fox | 2006 | Coronary Artery Disease (CAD) | Mortality | 1 |
06-031-03 | Fox Global Registry of Acute Coronary Events (GRACE) - Admission; Death or MI in Hospital | Fox | 2006 | Coronary Artery Disease (CAD) | Mortality | 0 |
06-031-04 | Fox Global Registry of Acute Coronary Events (GRACE) - Admission; Death or MI at 6 Months | Fox | 2006 | Coronary Artery Disease (CAD) | Mortality | 1 |
06-031-01 | Fox Global Registry of Acute Coronary Events (GRACE) - Admission; Death in Hospital | Fox | 2006 | Coronary Artery Disease (CAD) | Mortality | 0 |
06-031-02 | Fox Global Registry of Acute Coronary Events (GRACE) - Admission; Death at 6 Months | Fox | 2006 | Coronary Artery Disease (CAD) | Mortality | 1 |
01-023-01 | Fortescue 2001 | Fortescue | 2001 | Coronary Artery Disease (CAD) | MACCE+ | 0 |
12-038-01 | Forman 2012 | Forman | 2012 | Chronic Heart Failure (CHF) | Mortality | 0 |
13-091-01 | Fontanive 2013 | Fontanive | 2013 | Chronic Heart Failure (CHF) | Mortality | 0 |
97-008-01 | Fogelholm 1997 | Fogelholm | 1997 | Stroke | Mortality | 0 |
10-057-01 | Florence Chest Pain Rule | Conti | 2010 | Chest Pain | MACE | 1 |
08-014-01 | Fitzpatrick 2008 | Fitzpatrick | 2008 | Chronic Heart Failure (CHF) | Right Ventricular Failure | 0 |
14-049-01 | Figueiredo 2014 | Figueiredo | 2014 | Stroke | Arrhythmia | 1 |
12-020-01 | Fesmire 2012 - MI | Fesmire | 2012 | Coronary Artery Disease (CAD) | Myocardial Infarction (MI) | 0 |
12-020-02 | Fesmire 2012 - ACS | Fesmire | 2012 | Coronary Artery Disease (CAD) | Acute Coronary Syndrome (ACS) | 0 |
09-019-01 | Ferro 2009 | Ferro | 2009 | Stroke | Functional Outcome | 2 |
13-102-02 | Ferreyro 2013 - Death or Cancer | Ferreyro | 2013 | Venous Thromboembolism (VTE) | Composite | 0 |
13-102-01 | Ferreyro 2013 - Cancer | Ferreyro | 2013 | Venous Thromboembolism (VTE) | Cancer | 0 |
04-022-01 | Felker 2004 | Felker | 2004 | Chronic Heart Failure (CHF) | Mortality | 0 |
95-006-01 | Feinberg 1995 - In-Hospital Mortality | Feinberg | 1995 | Coronary Artery Disease (CAD) | Mortality | 0 |
95-006-02 | Feinberg 1995 - CHF | Feinberg | 1995 | Coronary Artery Disease (CAD) | Chronic Heart Failure (CHF) | 0 |
95-006-05 | Feinberg 1995 - Cardiogenic Shock | Feinberg | 1995 | Coronary Artery Disease (CAD) | Cardiogenic Shock | 0 |
95-006-03 | Feinberg 1995 - AV Block | Feinberg | 1995 | Coronary Artery Disease (CAD) | Atrioventricular Block | 0 |
95-006-04 | Feinberg 1995 - Atrial Fibrillation | Feinberg | 1995 | Coronary Artery Disease (CAD) | Arrhythmia | 0 |
95-006-06 | Feinberg 1995 - 1-Year Mortality | Feinberg | 1995 | Coronary Artery Disease (CAD) | Mortality | 0 |
06-039-01 | Fast-Track Failure (FTF) Score | Constantinides | 2006 | Cardiac Surgery | Composite | 1 |
04-017-01 | Family History Score (FHS) | Panagiotakos | 2004 | Population Sample | Coronary Artery Disease (CAD) | 0 |
13-100-04 | Faeh 2013 - TC Model, No Diabetes or CVD | Faeh | 2013 | Population Sample | Mortality | 0 |
13-100-02 | Faeh 2013 - TC Model, All Participants | Faeh | 2013 | Population Sample | Mortality | 0 |
13-100-03 | Faeh 2013 - A1C Model, No Diabetes | Faeh | 2013 | Population Sample | Mortality | 0 |
13-100-01 | Faeh 2013 - A1C Model, All Participants | Faeh | 2013 | Population Sample | Mortality | 0 |
10-020-01 | Evaluation Study of
Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) | O'Connor | 2010 | Chronic Heart Failure (CHF) | Mortality | 0 |
01-010-01 | Evaluation of Methods and Management of Acute Coronary Events (EMMACE) | Dorsch | 2001 | Coronary Artery Disease (CAD) | Mortality | 1 |
08-049-01 | Evaluation of Guidelines in SYncope Study (EGSYS) Score | Del Rosso | 2008 | Syncope | Syncope | 1 |
12-054-01 | EuroSCORE II | Nashef | 2012 | Cardiac Surgery | Mortality | 65 |
14-017-01 | European coLlaboration on Acute decompeNsated Heart Failure (ÉLAN-HF) Score | Salah | 2014 | Chronic Heart Failure (CHF) | Mortality | 1 |
11-008-02 | EuroHeart STEMI PCI Score | de Mulder | 2011 | Coronary Artery Disease (CAD) | Mortality | 0 |
11-008-01 | EuroHeart PCI Score | de Mulder | 2011 | Coronary Artery Disease (CAD) | Mortality | 0 |
05-030-01 | Essen Stroke Risk Score (ESRS) | Diener | 2005 | Stroke | Stroke | 4 |
06-003-01 | Essen intracerebral haemorrhage (ICH) Score - Mortality | Weimar | 2006 | Stroke | Mortality | 2 |
06-003-02 | Essen intracerebral haemorrhage (ICH) Score - Functional Outcome | Weimar | 2006 | Stroke | Functional Outcome | 2 |
92-009-01 | Esdaile 1992 | Esdaile | 1992 | Chronic Heart Failure (CHF) | Mortality | 0 |
10-027-01 | Ergelen 2010 | Ergelen | 2010 | Coronary Artery Disease (CAD) | Mortality | 0 |
10-004-01 | Ergelen 2010 | Ergelen | 2010 | Coronary Artery Disease (CAD) | Stent Thrombosis | 0 |
03-025-01 | Enhanced Feedback for Effective Cardiac Treatment (EFFECT) Score - 30 Days | Lee | 2003 | Chronic Heart Failure (CHF) | Mortality | 5 |
03-025-02 | Enhanced Feedback for Effective Cardiac Treatment (EFFECT) Score - 1 Year | Lee | 2003 | Chronic Heart Failure (CHF) | Mortality | 2 |
08-031-01 | Endovascular Aneurysm Repair (EVAR) Risk Assessment (ERA) - Technical Success | Barnes | 2008 | Aortic Disease | Technical Success | 1 |
08-031-13 | Endovascular Aneurysm Repair (EVAR) Risk Assessment (ERA) - Ruptures | Barnes | 2008 | Aortic Disease | Rupture | 0 |
08-031-11 | Endovascular Aneurysm Repair (EVAR) Risk Assessment (ERA) - Migrations | Barnes | 2008 | Aortic Disease | Migrations | 0 |
08-031-08 | Endovascular Aneurysm Repair (EVAR) Risk Assessment (ERA) - Mid-term Re-interventions | Barnes | 2008 | Aortic Disease | Re-Intervention | 2 |
08-031-10 | Endovascular Aneurysm Repair (EVAR) Risk Assessment (ERA) - Mid-term Graft Complicatioins | Barnes | 2008 | Aortic Disease | Graft Complications | 1 |
08-031-17 | Endovascular Aneurysm Repair (EVAR) Risk Assessment (ERA) - Mid-term Endoleak Type II | Barnes | 2008 | Aortic Disease | Endoleak | 2 |
08-031-15 | Endovascular Aneurysm Repair (EVAR) Risk Assessment (ERA) - Mid-term Endoleak Type I | Barnes | 2008 | Aortic Disease | Endoleak | 2 |
08-031-07 | Endovascular Aneurysm Repair (EVAR) Risk Assessment (ERA) - Initial Re-interventions | Barnes | 2008 | Aortic Disease | Re-Intervention | 2 |
08-031-09 | Endovascular Aneurysm Repair (EVAR) Risk Assessment (ERA) - Initial Graft Complications | Barnes | 2008 | Aortic Disease | Graft Complications | 1 |
08-031-16 | Endovascular Aneurysm Repair (EVAR) Risk Assessment (ERA) - Initial Endoleak Type II | Barnes | 2008 | Aortic Disease | Endoleak | 2 |
08-031-14 | Endovascular Aneurysm Repair (EVAR) Risk Assessment (ERA) - Initial Endoleak Type I | Barnes | 2008 | Aortic Disease | Endoleak | 2 |
08-031-02 | Endovascular Aneurysm Repair (EVAR) Risk Assessment (ERA) - Initial Clinical Success | Barnes | 2008 | Aortic Disease | Clinical Success | 1 |
08-031-06 | Endovascular Aneurysm Repair (EVAR) Risk Assessment (ERA) - Early Death | Barnes | 2008 | Aortic Disease | Mortality | 2 |
08-031-12 | Endovascular Aneurysm Repair (EVAR) Risk Assessment (ERA) - Convert to Open Repair | Barnes | 2008 | Aortic Disease | Convert to Open Repair | 0 |
08-031-05 | Endovascular Aneurysm Repair (EVAR) Risk Assessment (ERA) - Aneurysm-Related Death | Barnes | 2008 | Aortic Disease | Mortality | 2 |
08-031-04 | Endovascular Aneurysm Repair (EVAR) Risk Assessment (ERA) - 5-Year Survival | Barnes | 2008 | Aortic Disease | Mortality | 1 |
08-031-03 | Endovascular Aneurysm Repair (EVAR) Risk Assessment (ERA) - 3-Year Survival | Barnes | 2008 | Aortic Disease | Mortality | 2 |
13-089-01 | Enajat 2013 | Enajat | 2013 | Post-Operative | Venous Thromboembolism (VTE) | 0 |
14-035-01 | Emergency Department Assessment of Chest Pain Score (EDACS) | Than | 2014 | Chest Pain | MACE | 1 |
09-022-01 | Embolization Prognostic Risk Score | Starke | 2009 | Miscellaneous | Functional Outcome | 0 |
90-005-01 | Ellis 1990 - Success (Per Stenosis) | Ellis | 1990 | Coronary Artery Disease (CAD) | Technical Success | 0 |
90-005-03 | Ellis 1990 - Procedural Success | Ellis | 1990 | Coronary Artery Disease (CAD) | Technical Success | 0 |
90-005-04 | Ellis 1990 - Major Ischemic Procedural Complications | Ellis | 1990 | Coronary Artery Disease (CAD) | MACE | 0 |
90-005-02 | Ellis 1990 - Major Ischemic Complications (Per Stenosis) | Ellis | 1990 | Coronary Artery Disease (CAD) | MACE | 0 |
04-006-02 | Elhendy 2004 - Cardiac Events | Elhendy | 2004 | Coronary Artery Disease (CAD) | MACE | 0 |
04-006-01 | Elhendy 2004 - All Cause Mortality | Elhendy | 2004 | Coronary Artery Disease (CAD) | Mortality | 0 |
13-007-01 | El Hachioui 2013 | El Hachioui | 2013 | Stroke | Functional Outcome | 0 |
00-023-01 | El Chami 2000 | el Chami | 2000 | Stroke | mortality | 1 |
13-055-01 | Einav 2013 | Einav | 2013 | Cardiac Arrest | Mortality | 0 |
14-029-03 | Eichinger 2014 - 9 Months After End of Anticoagulatio | Eichinger | 2014 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 0 |
14-029-01 | Eichinger 2014 - 3 Weeks After End of Anticoagulatio | Eichinger | 2014 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 0 |
14-029-02 | Eichinger 2014 - 3 Months After End of Anticoagulatio | Eichinger | 2014 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 0 |
14-029-04 | Eichinger 2014 - 15 Months After End of Anticoagulatio | Eichinger | 2014 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 0 |
09-037-01 | Egorova 2009 | Egorova | 2009 | Aortic Disease | Mortality | 0 |
05-027-01 | Eggebrecht 2005 | Eggebrecht | 2005 | Aortic Disease | Mortality | 0 |
07-024-01 | Edinburgh Ruptured Aneurysm Score (ERAS) | Tambyraja | 2007 | Aortic Disease | Mortality | 3 |
13-067-01 | Echo Heart Failure Score (EHFS) | Carluccio | 2013 | Chronic Heart Failure (CHF) | Mortality | 0 |
04-012-01 | Eagle Global Registry of Acute Coronary Events (GRACE) Score | Eagle | 2004 | Coronary Artery Disease (CAD) | Mortality | 6 |
09-030-01 | Dyssynchrony, posterolateral Scar location and Creatinine (DSC) Index | Leyva | 2009 | Chronic Heart Failure (CHF) | Mortality | 0 |
14-032-01 | DWI ASPECTS , ACA territory involvement, M1 SVS, and Hyperglycemia (DASH) Score | Shimoyama | 2014 | Stroke | MMI | 0 |
91-006-01 | Dundee Coronary Risk-Disk | Tunstall-Pedoe | 1991 | Population Sample | Coronary Artery Disease (CAD) | 1 |
09-046-01 | Duke Sudden Cardiac Death (SCD) Risk Score | Atwater | 2009 | Coronary Artery Disease (CAD) | Mortality | 1 |
13-108-02 | Dorresteijn 2013 - Model B (Carotid Ultrasound) | Dorresteijn | 2013 | Coronary Artery Disease (CAD) | MACCE | 0 |
11-038-01 | Dorresteijn 2011 | Dorresteijn | 2011 | Population Sample | MACCE | 0 |
14-023-01 | Dodson 2014 | Dodson | 2014 | Chronic Heart Failure (CHF) | Composite | 0 |
01-016-01 | Dixon 2001 | Dixon | 2001 | Coronary Artery Disease (CAD) | MACCE | 0 |
92-003-01 | Dilger 1992 | Dilger | 1992 | Chest Pain | Myocardial Infarction (MI) | 1 |
04-011-01 | Diercks 2004 | Diercks | 2004 | Chest Pain | MACE | 1 |
04-024-02 | Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe (DECODE) - Women, 5 Years | Balkau | 2004 | Population Sample | Mortality | 0 |
04-024-04 | Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe (DECODE) - Women, 10 Years | Balkau | 2004 | Population Sample | Mortality | 0 |
04-024-01 | Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe (DECODE) - Men, 5 Years | Balkau | 2004 | Population Sample | Mortality | 0 |
04-024-03 | Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe (DECODE) - Men, 10 Years | Balkau | 2004 | Population Sample | Mortality | 1 |
06-021-01 | Diabetes Audit and Research in Tayside, Scotland (DARTS) | Donnan | 2006 | Population Sample | MACE | 4 |
14-002-01 | Dhoble 2014 | Dhoble | 2014 | Chest Pain | MACE | 0 |
92-014-02 | Detrano 1992 - Triple Vessel/Left Main Disease | Detrano | 1992 | Coronary Artery Disease (CAD) | Coronary Artery Disease (CAD) | 1 |
92-014-01 | Detrano 1992 - Any Obstruction | Detrano | 1992 | Coronary Artery Disease (CAD) | Coronary Artery Disease (CAD) | 2 |
92-005-01 | Detrano 1992 | Davis | 1992 | Population Sample | Chronic Heart Failure (CHF) | 0 |
09-004-01 | DES Real-world Incremental Value in the erA of percutaneous revascularizaTION (DERIVATION) Score | Capodanno | 2009 | Coronary Artery Disease (CAD) | Stent Thrombosis | 0 |
05-002-01 | DeRose 2005 | DeRose | 2005 | Chronic Heart Failure (CHF) | Mortality | 0 |
12-075-01 | Dense cerebral artery sign/early infarct signs on admission CT scan, prestroke modified Rankin Scale (mRS) score, Age, Glucose level at baseline, Onset-to-treatment time, and baseline National Institutes of Health Stroke Scale score (DRAGON) | Strbian | 2012 | Stroke | Functional Outcome | 9 |
13-005-01 | den Exter 2013 | den Exter | 2013 | Venous Thromboembolism (VTE) | Mortality | 1 |
12-081-01 | del Rio-Espinola 2012 | del Rio-Espinola | 2012 | Stroke | Hemorrhagic Transformation | 1 |
11-042-01 | Decousus 2011 | Decousus | 2011 | Population Sample | Hemorrhage | 0 |
12-012-01 | De Feo 2012 | De Feo | 2012 | Cardiac Surgery | Mortality | 0 |
11-010-01 | de Boer 2011 | de Boer | 2011 | Coronary Artery Disease (CAD) | Mortality | 0 |
07-016-01 | Davenport 2007 | Davenport | 2007 | Post-Operative | MACE | 0 |
01-015-01 | Daniel 2001 | Daniel | 2001 | Venous Thromboembolism (VTE) | Pulmonary Hypertension | 0 |
12-052-01 | Dangas 2012 | Dangas | 2012 | Coronary Artery Disease (CAD) | Stent Thrombosis | 0 |
04-014-01 | Danciu 2004 - Discharge | Danciu | 2004 | Cardiac Arrest | Mortality | 0 |
04-014-03 | Danciu 2004 - 3 Months | Danciu | 2004 | Cardiac Arrest | Mortality | 0 |
04-014-02 | Danciu 2004 - 1 Month | Danciu | 2004 | Cardiac Arrest | Mortality | 0 |
11-053-01 | Damman 2011 | Damman | 2011 | Coronary Artery Disease (CAD) | Mortality | 0 |
12-009-01 | D-dimer, Age, Sex, Hormonal therapy (DASH) Prediction Rule | Tosetto | 2012 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 0 |
09-013-01 | Cygankiewicz 2009 | Cygankiewicz | 2009 | Chronic Heart Failure (CHF) | Mortality | 0 |
13-066-01 | CVA, Albumin, Re-HTx, Renal dysfunction, and Sternotomies (CARRS) Score | Schulze | 2013 | Chronic Heart Failure (CHF) | Mortality | 0 |
05-031-01 | Customized Probability Index (CPI) | Kertai | 2005 | Cardiac Surgery | Mortality | 1 |
14-027-01 | Cuschieri 2014 | Cuschieri | 2014 | Coronary Artery Disease (CAD) | Hemorrhage | 0 |
05-001-01 | CUORE Equation | Ferrario | 2005 | Population Sample | MACE | 0 |
09-023-01 | Cruz-Gonzalez 2009 | Cruz-Gonzalez | 2009 | Valve Disease | Technical Success | 1 |
11-012-01 | Critical status, Renal dysfunction, Right atrial pressure, and Cardiac output (CRRAC) the AV Score | Elmariah | 2011 | Valve Disease | Mortality | 0 |
11-046-02 | Creutzfeldt 2011 - Non-do-not-attempt-resuscitation(DNAR) Patients Only | Creutzfeldt | 2011 | Stroke | Functional Outcome | 0 |
11-046-01 | Creutzfeldt 2011 - All Patients | Creutzfeldt | 2011 | Stroke | Functional Outcome | 0 |
00-004-02 | Coselli 2000 - Paraplegia | Coselli | 2000 | Aortic Disease | Functional Outcome | 0 |
00-004-01 | Coselli 2000 - Operative Mortality | Coselli | 2000 | Aortic Disease | Mortality | 0 |
05-019-01 | Cortigiani 2005 | Cortigiani | 2005 | Coronary Artery Disease (CAD) | Mortality | 0 |
14-057-01 | Cortical involvement of ICH, Age, Volume, and Early seizure within 7 days of ICH (CAVE) Score | Haapaniemi | 2014 | Stroke | Seizure | 1 |
14-030-01 | Corrales-Medina 2014 | Corrales-Medina | 2014 | Population Sample | MACE | 1 |
13-090-01 | COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter Registry (CONFIRM) Score | Hadamitzky | 2013 | Chest Pain | Mortality | 1 |
95-004-01 | Coppola 1995 | Coppola | 1995 | Population Sample | Stroke | 0 |
94-007-02 | Copenhagen - Women | Truelsen | 1994 | Population Sample | Stroke | 0 |
94-007-01 | Copenhagen - Men | Truelsen | 1994 | Population Sample | Stroke | 1 |
05-009-02 | Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) - 30 Days | Halkin | 2005 | Coronary Artery Disease (CAD) | Mortality | 2 |
05-009-01 | Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) - 1 Year | Halkin | 2005 | Coronary Artery Disease (CAD) | Mortality | 3 |
08-029-01 | Constans 2008 | Constans | 2008 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 2 |
03-021-01 | Constans 2003 | Constans | 2003 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 1 |
01-019-01 | Constans 2001 | Constans | 2001 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 2 |
13-032-01 | Conrad 2013 | Conrad | 2013 | Carotid Disease | Mortality | 0 |
10-005-01 | Congestive heart failure/LV dysfunction, Hypertension, Age, Diabetes mellitus, Stroke/TIA/TE, Vascular disease, Age, Sex category (CHA2DS2-VASc) | Lip | 2010 | Arrhythmia | Systemic Embolization | 45 |
94-001-01 | Congestive Heart Failure Mortality- Time-Insensitive Predictive Instruments (CHFM-TIPI) | Selker | 1994 | Chronic Heart Failure (CHF) | Mortality | 0 |
00-024-01 | Congestion Score | Lucas | 2000 | Chronic Heart Failure (CHF) | Congestion | 0 |
13-073-02 | Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE)-AF - Augmented Model | Alonso | 2013 | Population Sample | Arrhythmia | 3 |
13-073-01 | Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) -AF - Simple Model | Alonso | 2013 | Population Sample | Arrhythmia | 3 |
13-060-01 | COhorte de Patients ARTeriopathes (COPART) Risk Score | Pros | 2013 | Peripheral Vascular Disease (PVD) | MACCE | 1 |
10-055-02 | Clinical Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Score (CSS) - Mortality | Garg | 2010 | Coronary Artery Disease (CAD) | Mortality | 3 |
10-055-01 | Clinical Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Score (CSS) - MACE | Garg | 2010 | Coronary Artery Disease (CAD) | MACCE | 12 |
03-028-01 | Clinical Outcomes Assessment Program (COAP) Model | Maynard | 2003 | Cardiac Surgery | Mortality | 2 |
92-007-02 | Cleveland Clinic Score - Mortality | Higgins | 1992 | Coronary Artery Disease (CAD) | Mortality | 12 |
92-007-01 | Cleveland Clinic Score - MACE | Higgins | 1992 | Coronary Artery Disease (CAD) | MACCE+ | 6 |
97-018-02 | Cleveland Clinic Foundation model - Death, MI, or Emergency Bypass | Ellis | 1997 | Coronary Artery Disease (CAD) | MACE | 0 |
97-018-01 | Cleveland Clinic Foundation model - Death | Ellis | 1997 | Coronary Artery Disease (CAD) | Mortality | 4 |
05-025-04 | Clayton 2005 - Stroke | Clayton | 2005 | Coronary Artery Disease (CAD) | Stroke | 0 |
05-025-03 | Clayton 2005 - MI | Clayton | 2005 | Coronary Artery Disease (CAD) | Myocardial Infarction (MI) | 0 |
05-025-01 | Clayton 2005 - Death, MI, or Stroke | Clayton | 2005 | Coronary Artery Disease (CAD) | MACCE | 0 |
05-025-02 | Clayton 2005 - Death | Clayton | 2005 | Coronary Artery Disease (CAD) | Mortality | 0 |
12-024-01 | Cioffi 2012 | Cioffi | 2012 | Valve Disease | MACCE | 0 |
97-015-01 | CICSP Renal Risk Stratification Algorithm | Chertow | 1997 | Cardiac Surgery | Renal Outcomes | 2 |
01-025-01 | Ciampi 2001 - Women | Ciampi | 2001 | Population Sample | MACE | 0 |
14-022-02 | Chyu 2014 - Women | Chyu | 2014 | Chronic Heart Failure (CHF) | Mortality | 1 |
14-022-01 | Chyu 2014 - Men | Chyu | 2014 | Chronic Heart Failure (CHF) | Mortality | 1 |
14-022-03 | Chyu 2014 - Entire Population | Chyu | 2014 | Chronic Heart Failure (CHF) | Mortality | 2 |
10-058-01 | Chumbler 2010 | Chumbler | 2010 | Stroke | Pneumonia | 3 |
12-003-01 | Chong 2012 | Chong | 2012 | Population Sample | CIN | 0 |
12-039-01 | Choke 2012 | Choke | 2012 | Aortic Disease | Mortality | 0 |
08-042-01 | Cho Modified ICH (MICH) Score | Cho | 2008 | Stroke | Mortality | 3 |
10-033-01 | Chiostri 2010 | Chiostri | 2010 | Coronary Artery Disease (CAD) | Mortality | 1 |
97-006-01 | Chin 1997 | Chin | 1997 | Chronic Heart Failure (CHF) | Composite | 0 |
12-010-03 | Chien 2012 - LDL Based Model | Chien | 2012 | Population Sample | Coronary Artery Disease (CAD) | 1 |
12-010-01 | Chien 2012 - Clinical Model | Chien | 2012 | Population Sample | Coronary Artery Disease (CAD) | 1 |
12-010-02 | Chien 2012 - Cholesterol Based Model | Chien | 2012 | Population Sample | Coronary Artery Disease (CAD) | 1 |
10-043-01 | Chien 2010 - Clinical Model | Chien | 2010 | Population Sample | Stroke | 0 |
10-043-02 | Chien 2010 - Biochemical Model | Chien | 2010 | Population Sample | Stroke | 0 |
01-006-01 | CHF, Hypertension, Age, DM, History of Stroke or TIA (CHADS2) | Gage | 2001 | Arrhythmia | Stroke | 37 |
14-011-01 | Chen 2014 | Chen | 2014 | Coronary Artery Disease (CAD) | Renal Outcomes | 0 |
12-057-01 | Chen 2012 | Chen | 2012 | Coronary Artery Disease (CAD) | No Reflow | 0 |
07-014-01 | Chen 2007 | Chen | 2007 | Coronary Artery Disease (CAD) | Myocardial Infarction (MI) | 1 |
06-018-01 | Chen 2006 | Chen | 2006 | Venous Thromboembolism (VTE) | Venous Thromboembolism (VTE) | 0 |
08-033-01 | Chauleur 2008 | Chauleur | 2008 | Pregnancy | Venous Thromboembolism (VTE) | 0 |
06-020-01 | Chaudhuri 2006 | Chaudhuri | 2006 | Cardiac Surgery | Intestinal Ischemia | 0 |
06-005-04 | Chang 2006 - Day 5 | Chang | 2006 | Coronary Artery Disease (CAD) | Mortality | 4 |
06-005-03 | Chang 2006 - Day 2 | Chang | 2006 | Coronary Artery Disease (CAD) | Mortality | 4 |
06-005-01 | Chang 2006 - Day 0 | Chang | 2006 | Coronary Artery Disease (CAD) | Mortality | 4 |
06-005-02 | Chang 2006 - 3 Hours | Chang | 2006 | Coronary Artery Disease (CAD) | Mortality | 4 |
11-049-01 | Chamberlain 2011 | Chamberlain | 2011 | Population Sample | Arrhythmia | 0 |
06-038-02 | Centofanti 2006 - Preoperative Predictors | Centofanti | 2006 | Aortic Disease | Mortality | 1 |
06-038-01 | Centofanti 2006 - Perioperative Predictors | Centofanti | 2006 | Aortic Disease | Mortality | 0 |
11-022-01 | Cederholm 2011 | Cederholm | 2011 | Population Sample | MACCE | 1 |
97-002-01 | Catalan Study (CS) Model | Pons | 1997 | Cardiac Surgery | Mortality | 1 |
13-109-02 | Cardiovascular Monitoring Unit in Northern Italy (CAMUNI) - Women | Veronesi | 2013 | Population Sample | MACE | 1 |
13-109-01 | Cardiovascular Monitoring Unit in Northern Italy (CAMUNI) - Men | Veronesi | 2013 | Population Sample | MACE | 1 |
06-030-01 | CardioVascular Medicine Heart Failure (CVM-HF) Index | Senni | 2006 | Chronic Heart Failure (CHF) | Mortality | 0 |
02-003-02 | Cardiovascular Health Study (CHS) - Women | Lumley | 2002 | Population Sample | Stroke | 0 |
02-003-01 | Cardiovascular Health Study (CHS) - Men | Lumley | 2002 | Population Sample | Stroke | 1 |
00-019-01 | Cardiovascular Event Reduction Tool (CERT) | L'Italien | 2000 | Population Sample | MACE | 0 |
16-004-01 | Cardiac-specific Charlson Comorbidity Index (CCI) | Moodley | 2016 | Population Sample | MACE | 1 |
05-032-01 | Cardiac Surgery Score (CASUS) | Hekmat | 2005 | Cardiac Surgery | Mortality | 2 |
99-015-02 | Cardiac Risk Score (CRS) - Prolonged ICU LOS | Wong | 1999 | Coronary Artery Disease (CAD) | Prolonged LOS | 0 |
99-015-03 | Cardiac Risk Score (CRS) - Mortality | Wong | 1999 | Coronary Artery Disease (CAD) | Mortality | 0 |
99-015-01 | Cardiac Risk Score (CRS) - Delayed Extubation | Wong | 1999 | Coronary Artery Disease (CAD) | Delayed Extubation | 1 |
01-013-01 | Cardiac Disease in Pregnancy (CARPREG) | Siu | 2001 | Pregnancy | Composite | 4 |
01-002-03 | Cardiac Anesthesia Risk Evaluation (CARE) - Prolonged LOS | Dupuis | 2001 | Cardiac Surgery | Prolonged LOS | 1 |
01-002-01 | Cardiac Anesthesia Risk Evaluation (CARE) - Mortality | Dupuis | 2001 | Cardiac Surgery | Mortality | 3 |
01-002-02 | Cardiac Anesthesia Risk Evaluation (CARE) - Morbidity | Dupuis | 2001 | Cardiac Surgery | Composite | 1 |
13-106-01 | Cardiac and Comorbid Conditions Heart Failure (3C-HF) Score - Logistic | Senni | 2013 | Chronic Heart Failure (CHF) | Mortality | 2 |
13-106-02 | Cardiac and Comorbid Conditions Heart Failure (3C-HF) Score - Additive | Senni | 2013 | Chronic Heart Failure (CHF) | Mortality | 1 |
06-002-01 | Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity (CHARM) - CV Death or HF Hospitalization | Pocock | 2006 | Chronic Heart Failure (CHF) | MACE | 1 |
06-002-02 | Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity (CHARM) - All Cause Mortality | Pocock | 2006 | Chronic Heart Failure (CHF) | Mortality | 0 |
13-098-01 | Canada Acute Coronary Syndrome (C-ACS) Risk Score | Huynh | 2013 | Coronary Artery Disease (CAD) | Mortality | 2 |
11-039-01 | Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) Long-Term Mortality Risk Score | Roe | 2011 | Coronary Artery Disease (CAD) | Mortality | 0 |
09-014-01 | Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) | Subherwal | 2009 | Coronary Artery Disease (CAD) | Hemorrhage | 10 |
93-002-01 | Campana 1993 | Campana | 1993 | Chronic Heart Failure (CHF) | Mortality | 0 |
95-008-02 | Calvin 1995 - Recurrent MI and Death | Calvin | 1995 | Coronary Artery Disease (CAD) | MACE | 0 |
95-008-01 | Calvin 1995 - Major Cardiac Complications | Calvin | 1995 | Coronary Artery Disease (CAD) | MACE | 0 |
10-050-02 | Calvillo-King 2010 - Patient-Friendly Risk Score | Calvillo-King | 2010 | Carotid Disease | Stroke | 0 |
10-050-01 | Calvillo-King 2010 - CEA-8 Clinical Risk Score | Calvillo-King | 2010 | Carotid Disease | MANE | 0 |
00-017-01 | California Risk Score | Johnston | 2000 | Stroke | Stroke | 2 |
00-009-01 | Califf 2000 - Without Angiography | Califf | 2000 | Coronary Artery Disease (CAD) | Mortality | 0 |
00-009-02 | Califf 2000 - With Angiography | Califf | 2000 | Coronary Artery Disease (CAD) | Mortality | 0 |
97-004-01 | Califf 1997 | Califf | 1997 | Coronary Artery Disease (CAD) | Mortality | 0 |
90-003-01 | Cabin 1990 | Cabin | 1990 | Arrhythmia | Systemic Embolization | 0 |
13-112-01 | CABG Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Score - All-Cause Death | Farooq | 2013 | Coronary Artery Disease (CAD) | Mortality | 1 |
13-112-03 | CABG Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Score - All-Cause Revascularization | Farooq | 2013 | Coronary Artery Disease (CAD) | Revascularization | 0 |
13-112-02 | CABG Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Score - All-Cause Death/CVA/MI | Farooq | 2013 | Coronary Artery Disease (CAD) | MACCE | 0 |
14-009-01 | Brunner 2014 | Brunner | 2014 | Population Sample | Arrhythmia | 1 |
12-043-01 | Brooks 2012 | Brooks | 2012 | Coronary Artery Disease (CAD) | MACCE | 0 |
93-006-01 | Broderick 1993 | Broderick | 1993 | Stroke | Mortality | 2 |
09-032-01 | British Columbia-Percutaneous Coronary Intervention (BC-PCI) Risk Score | Hamburger | 2009 | Coronary Artery Disease (CAD) | Mortality | 1 |
14-007-02 | Bray Model B | Bray | 2014 | Stroke | Mortality | 2 |
14-007-01 | Bray Model A | Bray | 2014 | Stroke | Mortality | 2 |
14-064-02 | Bova Score - In Hospital PE-Related Complications | Bova | 2014 | Venous Thromboembolism (VTE) | Composite | 0 |
14-064-03 | Bova Score - 30 Day PE-Related Mortality | Bova | 2014 | Venous Thromboembolism (VTE) | Mortality | 0 |
14-064-01 | Bova Score - 30 Day PE-Related Complications | Bova | 2014 | Venous Thromboembolism (VTE) | Composite | 1 |
03-010-01 | Bouvy 2003 | Bouvy | 2003 | Chronic Heart Failure (CHF) | Mortality | 1 |
12-008-03 | Bouleti 2012 - 5 Years | Bouleti | 2012 | Valve Disease | Functional Outcome | 0 |
12-008-01 | Bouleti 2012 - 15 Years | Bouleti | 2012 | Valve Disease | Composite | 0 |
12-008-02 | Bouleti 2012 - 10 Years | Bouleti | 2012 | Valve Disease | Functional Outcome | 0 |
10-038-01 | Bosner 2010 | Bosner | 2010 | Chest Pain | Coronary Artery Disease (CAD) | 1 |
10-011-01 | Borleffs 2010 - Non-Ischemic Heart Disease | Borleffs | 2010 | Chronic Heart Failure (CHF) | Mortality | 0 |
10-011-02 | Borleffs 2010 - Ischemic Heart Disease | Borleffs | 2010 | Chronic Heart Failure (CHF) | Mortality | 0 |
14-033-01 | Boehme 2014 | Boehme | 2014 | Stroke | SIRS | 0 |
06-024-02 | Bjork 2006 - Base Model + Additional Characteristics | Bjork | 2006 | Chest Pain | Acute Coronary Syndrome (ACS) | 0 |
06-024-01 | Bjork 2006 - Base Model | Bjork | 2006 | Chest Pain | Acute Coronary Syndrome (ACS) | 0 |
14-005-02 | BIO-VIenna and Ludwigshafen Coronary Artery Disease (VILCAD) score (Without LVEF) | Kleber | 2014 | Coronary Artery Disease (CAD) | Mortality | 0 |
12-044-04 | Bilchick 2012 - 4 Years | Bilchick | 2012 | Chronic Heart Failure (CHF) | Mortality | 1 |
12-044-03 | Bilchick 2012 - 3 Years | Bilchick | 2012 | Chronic Heart Failure (CHF) | Mortality | 0 |
12-044-02 | Bilchick 2012 - 2 Years | Bilchick | 2012 | Chronic Heart Failure (CHF) | Mortality | 0 |
12-044-01 | Bilchick 2012 - 1 Year | Bilchick | 2012 | Chronic Heart Failure (CHF) | Mortality | 0 |
00-006-01 | Bernstein-Parsonnet Score | Bernstein | 2000 | Cardiac Surgery | Mortality | 5 |
11-059-03 | Berg 2011 - Model 3, Preop + Intraop | Berg | 2011 | Cardiac Surgery | Mortality | 0 |
11-059-02 | Berg 2011 - Model 2, Preop + Intraop | Berg | 2011 | Cardiac Surgery | Mortality | 0 |
11-059-01 | Berg 2011 - Model 1, Preop | Berg | 2011 | Cardiac Surgery | Mortality | 0 |
99-014-01 | Ben-Ari 1999 | Ben-Ari | 1999 | Miscellaneous | Hemorrhage | 0 |
14-015-01 | Bekelis 2014 - Unfavorable Discharge in Unruptured Aneurysms | Bekelis | 2014 | Unruptured Cerebral Aneurysm | Unfavorable Discharge | 0 |
14-062-01 | Bekelis 2014 - Unfavorable Discharge in Unruptured Aneurysms | Bekelis | 2014 | Unruptured Cerebral Aneurysm | Unfavorable Discharge | 0 |
14-062-02 | Bekelis 2014 - Unfavorable Discharge in Ruptured Aneurysms | Bekelis | 2014 | Stroke | Unfavorable Discharge | 0 |
14-015-02 | Bekelis 2014 - Unfavorable Discharge in Ruptured Aneurysms | Bekelis | 2014 | Stroke | Unfavorable Discharge | 0 |
14-062-04 | Bekelis 2014 - Prolonged LOS in Ruptured Aneurysms | Bekelis | 2014 | Stroke | Prolonged LOS | 0 |
14-015-04 | Bekelis 2014 - Prolonged Hospital Stay in Ruptured Aneurysms | Bekelis | 2014 | Stroke | Prolonged LOS | 0 |
14-062-03 | Bekelis 2014 - Death in Ruptured Aneurysms | Bekelis | 2014 | Ruptured and Unruptured Cerebral Aneurysm | Mortality | 0 |
14-015-03 | Bekelis 2014 - Death in Ruptured Aneurysms | Bekelis | 2014 | Stroke | Mortality | 0 |
11-057-01 | Beer 2011 - Health in Men Study (HIMS)-CVRS Point Score | Beer | 2011 | Population Sample | MACE | 0 |
11-057-02 | Beer 2011 - Health in Men Study (HIMS)-CVR Regression Model | Beer | 2011 | Population Sample | MACE | 0 |
12-002-01 | Beckers 2012 | Beckers | 2012 | Stroke | Prolonged LOS | 0 |
13-044-01 | Becker 2013 | Becker | 2013 | Aortic Disease | Functional Outcome | 0 |
09-015-01 | Beck 2009 - Open | Beck | 2009 | Aortic Disease | Mortality | 0 |
09-015-02 | Beck 2009 - EVAR | Beck | 2009 | Aortic Disease | Mortality | 0 |
12-083-01 | baseline blood Sugar, Early infarct signs and (hyper)Dense cerebral artery sign on admission computed tomography scan, Age, and NIH Stroke Scale on admission (SEDAN) | Strbian | 2012 | Stroke | Stroke | 12 |
13-009-02 | Barlera 2013 - 4 Years | Barlera | 2013 | Chronic Heart Failure (CHF) | Mortality | 0 |
13-009-01 | Barlera 2013 - 2 Years | Barlera | 2013 | Chronic Heart Failure (CHF) | Mortality | 0 |
14-042-01 | Barco 2014 | Barco | 2014 | Stroke | Functional Outcome | 0 |
11-006-01 | Baran 2011 | Baran | 2011 | Coronary Artery Disease (CAD) | Stent Thrombosis | 0 |
08-008-01 | Baran 2008 | Baran | 2008 | Coronary Artery Disease (CAD) | Stent Thrombosis | 1 |
11-048-01 | Banach Score | Filipiak | 2011 | Coronary Artery Disease (CAD) | Mortality | 1 |
07-005-01 | Bae 2007 | Bae | 2007 | Coronary Artery Disease (CAD) | Mortality | 0 |
11-030-01 | Badheka 2011 | Badheka | 2011 | Coronary Artery Disease (CAD) | PAD | 0 |
13-008-02 | Ayis 2013 - SSV | Ayis | 2013 | Stroke | Mortality | 0 |
13-008-01 | Ayis 2013 - FSV | Ayis | 2013 | Stroke | Mortality | 0 |
13-008-04 | Ayis 2013 - Age + NIHSS | Ayis | 2013 | Stroke | Mortality | 0 |
13-008-03 | Ayis 2013 - Age + BI | Ayis | 2013 | Stroke | Mortality | 0 |
07-034-01 | Australian Clinical Risk Index (ACRI) | Friedman | 2007 | Coronary Artery Disease (CAD) | Infection | 1 |
09-053-01 | AusSCORE | Reid | 2009 | Coronary Artery Disease (CAD) | Mortality | 1 |
11-009-01 | Aus-Aortic Valve Replacement (AVR) Score | Ariyaratne | 2011 | Cardiac Surgery | Mortality | 3 |
08-024-03 | Atsma 2008 - Model 3 | Atsma | 2008 | Population Sample | Peripheral Vascular Disease (PVD) | 0 |
08-024-02 | Atsma 2008 - Model 2 | Atsma | 2008 | Population Sample | Peripheral Vascular Disease (PVD) | 0 |
08-024-01 | Atsma 2008 - Model 1 | Atsma | 2008 | Population Sample | Peripheral Vascular Disease (PVD) | 0 |
03-019-07 | Atherosclerosis Risk in Communities (ARIC) risk score - Full Model, Women, Not Diabetic | Folsom | 2003 | Population Sample | MACE | 0 |
03-019-03 | Atherosclerosis Risk in Communities (ARIC) risk score - Full Model, Women, Diabetic | Folsom | 2003 | Population Sample | MACE | 0 |
03-019-08 | Atherosclerosis Risk in Communities (ARIC) risk score - Full Model, Men, Not Diabetic | Folsom | 2003 | Population Sample | MACE | 0 |
03-019-04 | Atherosclerosis Risk in Communities (ARIC) risk score - Full Model, Men, Diabetic | Folsom | 2003 | Population Sample | MACE | 0 |
03-019-05 | Atherosclerosis Risk in Communities (ARIC) risk score - Basic Model, Women, Not Diabetic | Folsom | 2003 | Population Sample | MACE | 0 |
03-019-01 | Atherosclerosis Risk in Communities (ARIC) risk score - Basic Model, Women, Diabetic | Folsom | 2003 | Population Sample | MACE | 3 |
03-019-06 | Atherosclerosis Risk in Communities (ARIC) risk score - Basic Model, Men, Not Diabetic | Folsom | 2003 | Population Sample | MACE | 0 |
03-019-02 | Atherosclerosis Risk in Communities (ARIC) risk score - Basic Model, Men, Diabetic | Folsom | 2003 | Population Sample | MACE | 3 |
07-029-02 | Assmann 2007 - Women | Assmann | 2007 | Population Sample | Stroke | 0 |
07-029-01 | Assmann 2007 - Men | Assmann | 2007 | Population Sample | MACE | 0 |
07-001-02 | ASSessing cardiovascular risk, using SIGN (ASSIGN) Score - Women | Woodward | 2007 | Population Sample | Composite | 0 |
07-001-01 | ASSessing cardiovascular risk, using SIGN (ASSIGN) Score - Men | Woodward | 2007 | Population Sample | Composite | 0 |
13-058-01 | ASCORE | Prieto-Merino | 2013 | Population Sample | MACCE | 0 |
16-005-01 | Arnold 2016 - 6-Month Full Model | Arnold | 2016 | Valve Disease | Functional Outcome | 0 |
16-005-03 | Arnold 2016 - 6-Month Clinical Model | Arnold | 2016 | Valve Disease | Functional Outcome | 0 |
16-005-02 | Arnold 2016 - 1-Year Full Model | Arnold | 2016 | Valve Disease | Functional Outcome | 0 |
16-005-04 | Arnold 2016 - 1-Year Clinical Model | Arnold | 2016 | Valve Disease | Functional Outcome | 0 |
14-067-01 | Arnold 2014 - 6 Months | Arnold | 2014 | Valve Disease | Composite | 0 |
14-067-02 | Arnold 2014 - 1 Year | Arnold | 2014 | Valve Disease | Composite | 0 |
05-014-01 | Armstrong 2005 | Armstrong | 2005 | Population Sample | MACE | 1 |
09-035-01 | Arima 2009 | Arima | 2009 | Population Sample | MACCE | 0 |
98-003-02 | Arboix 1998 - Clinical & Neuroimaging | Arboix | 1998 | Stroke | Mortality | 0 |
98-003-01 | Arboix 1998 - Clinical | Arboix | 1998 | Stroke | Mortality | 0 |
11-018-01 | Aortic Valve Replacement (AVR)Score | Swinkels | 2011 | Cardiac Surgery | Mortality | 1 |
99-016-01 | Anyanwu 1999 | Anyanwu | 1999 | Chronic Heart Failure (CHF) | Graft Survival | 0 |
09-007-01 | Antunes Score - Stroke | Antunes | 2009 | Coronary Artery Disease (CAD) | Stroke | 0 |
09-007-04 | Antunes Score - Respiratory Failure | Antunes | 2009 | Coronary Artery Disease (CAD) | Respiratory Failure | 0 |
09-007-03 | Antunes Score - Renal Outcome | Antunes | 2009 | Coronary Artery Disease (CAD) | Renal Outcomes | 0 |
09-007-02 | Antunes Score - Mediastinitis | Antunes | 2009 | Coronary Artery Disease (CAD) | Mediastinitis | 0 |
09-007-06 | Antunes Score - Composite | Antunes | 2009 | Coronary Artery Disease (CAD) | Composite | 0 |
09-007-05 | Antunes Score - CHF | Antunes | 2009 | Coronary Artery Disease (CAD) | Chronic Heart Failure (CHF) | 1 |
12-071-01 | Antoni 2012 | Antoni | 2012 | Coronary Artery Disease (CAD) | Composite | 0 |
13-095-01 | Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Stroke Risk Score | Singer | 2013 | Arrhythmia | Stroke | 1 |
11-029-01 | Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) | Fang | 2011 | Arrhythmia | Hemorrhage | 7 |
09-049-03 | Anselmino 2009 - type 2 diabetes mellitus (T2DM) | Anselmino | 2009 | Coronary Artery Disease (CAD) | MACCE | 0 |
09-049-01 | Anselmino 2009 - normal glucose regulation (NGR) | Anselmino | 2009 | Coronary Artery Disease (CAD) | MACCE | 0 |
09-049-02 | Anselmino 2009 - impaired glucose regulation (IGR) | Anselmino | 2009 | Coronary Artery Disease (CAD) | MACCE | 0 |
07-004-01 | Anderson 2007 - 30 Days | Anderson | 2007 | Coronary Artery Disease (CAD) | Mortality | 0 |
07-004-02 | Anderson 2007 - 1 Year | Anderson | 2007 | Coronary Artery Disease (CAD) | Mortality | 0 |
03-024-02 | Amphia Score - MACE | Huijskes | 2003 | Cardiac Surgery | MACE | 0 |
03-024-01 | Amphia Score - In Hospital Death | Huijskes | 2003 | Cardiac Surgery | Mortality | 0 |
03-024-03 | Amphia Score - Extended LOS on ICU | Huijskes | 2003 | Cardiac Surgery | Prolonged LOS | 0 |
13-071-01 | Amin 2013 | Amin | 2013 | Coronary Artery Disease (CAD) | Mortality | 1 |
10-016-01 | American Heart Association Get With the GuidelinesHeart Failure (AHA GWTG-HF) Risk Score | Peterson | 2010 | Chronic Heart Failure (CHF) | Mortality | 2 |
02-006-03 | American College of CardiologyNational Cardiovascular Data Registry (ACCNCDR) Model - No AMI Within 24 Hours | Shaw | 2002 | Coronary Artery Disease (CAD) | Mortality | 0 |
02-006-02 | American College of CardiologyNational Cardiovascular Data Registry (ACCNCDR) Model - AMI Within 24 Hours | Shaw | 2002 | Coronary Artery Disease (CAD) | Mortality | 0 |
02-006-01 | American College of CardiologyNational Cardiovascular Data Registry (ACCNCDR) Model - All Patients | Shaw | 2002 | Coronary Artery Disease (CAD) | Mortality | 2 |
99-018-01 | American College of Cardiology/American Heart Association (ACC/AHA) Score - Mortality | Eagle | 1999 | Cardiac Surgery | Mortality | 1 |
99-018-03 | American College of Cardiology/American Heart Association (ACC/AHA) Score - Mediastinitis | Eagle | 1999 | Cardiac Surgery | Mediastinitis | 0 |
99-018-02 | American College of Cardiology/American Heart Association (ACC/AHA) Score - CVA | Eagle | 1999 | Cardiac Surgery | Stroke | 0 |
14-020-01 | American College of Cardiology/American Heart Association (ACC/AHA) Pooled Cohort - White Women | Goff | 2014 | Population Sample | MACCE | 3 |
14-020-03 | American College of Cardiology/American Heart Association (ACC/AHA) Pooled Cohort - White Men | Goff | 2014 | Population Sample | MACCE | 3 |
14-020-02 | American College of Cardiology/American Heart Association (ACC/AHA) Pooled Cohort - African American Women | Goff | 2014 | Population Sample | MACCE | 0 |
14-020-04 | American College of Cardiology/American Heart Association (ACC/AHA) Pooled Cohort - African American Men | Goff | 2014 | Population Sample | MACCE | 2 |
16-001-01 | American College of Cardiology Transcatheter Aortic Valve Replacement (ACC TAVI) | Edwards | 2016 | Valve Disease | Mortality | 2 |
05-013-01 | Ambler Score | Ambler | 2005 | Cardiac Surgery | Mortality | 12 |
04-016-01 | Amar 2004 | Amar | 2004 | Coronary Artery Disease (CAD) | Arrhythmia | 0 |
14-066-01 | Allou 2014 | Allou | 2014 | Cardiac Surgery | Pneumonia | 1 |
00-007-01 | Alla 2000 - Ischemic | Alla | 2000 | Chronic Heart Failure (CHF) | Mortality | 1 |
00-007-02 | Alla 2000 - Dilated | Alla | 2000 | Chronic Heart Failure (CHF) | Mortality | 1 |
05-007-02 | Alehagen 2005 - Clinical Exam + Doppler Echo | Alehagen | 2005 | Chronic Heart Failure (CHF) | Mortality | 0 |
05-007-01 | Alehagen 2005 - Clinical Exam | Alehagen | 2005 | Chronic Heart Failure (CHF) | Mortality | 0 |
13-074-02 | Alcocer 2013 - Symptomatic | Alcocer | 2013 | Carotid Disease | Mortality | 0 |
13-074-01 | Alcocer 2013 - Asymptomatic | Alcocer | 2013 | Carotid Disease | Mortality | 1 |
11-023-01 | Agterof 2011 | Agterof | 2011 | Venous Thromboembolism (VTE) | Composite | 0 |
14-031-01 | Age, HR, history of CHF and Hypertension (ARC2H) Score | Imai | 2014 | Arrhythmia | Chronic Heart Failure (CHF) | 1 |
09-024-01 | Age, Creatinine, and left ventricular Ejection Fraction (ACEF) Score | Ranucci | 2009 | Cardiac Surgery | Mortality | 26 |
10-062-08 | Age, Blood pressure, Clinical weakness, Duration, Diabetes, Dual transient ischaemic attack, carotid Imaging (ABCD3-I) (90 Days) | Merwick | 2010 | Stroke | Stroke | 3 |
10-062-06 | Age, Blood pressure, Clinical weakness, Duration, Diabetes, Dual transient ischaemic attack, carotid Imaging (ABCD3-I) (7 Days) | Merwick | 2010 | Stroke | Stroke | 1 |
10-062-07 | Age, Blood pressure, Clinical weakness, Duration, Diabetes, Dual transient ischaemic attack, carotid Imaging (ABCD3-I) (28 Days) | Merwick | 2010 | Stroke | Stroke | 0 |
10-062-05 | Age, Blood pressure, Clinical weakness, Duration, Diabetes, Dual transient ischaemic attack, carotid Imaging (ABCD3-I) (2 Days) | Merwick | 2010 | Stroke | Stroke | 0 |
10-062-04 | Age, Blood pressure, Clinical weakness, Duration, Diabetes, Dual transient ischaemic attack (ABCD3) (90 Days) | Merwick | 2010 | Stroke | Stroke | 2 |
10-062-02 | Age, Blood pressure, Clinical weakness, Duration, Diabetes, Dual transient ischaemic attack (ABCD3) (7 Days) | Merwick | 2010 | Stroke | Stroke | 2 |
10-062-03 | Age, Blood pressure, Clinical weakness, Duration, Diabetes, Dual transient ischaemic attack (ABCD3) (28 Days) | Merwick | 2010 | Stroke | Stroke | 0 |
10-062-01 | Age, Blood pressure, Clinical weakness, Duration, Diabetes, Dual transient ischaemic attack (ABCD3) (2 Days) | Merwick | 2010 | Stroke | Stroke | 0 |
07-032-01 | Age, Blood pressure, Clinical features, Duration, Diabetes (ABCD2) | Johnston | 2007 | Stroke | Stroke | 16 |
08-046-01 | Age, Blood pressure, Clinical features, Duration of symptoms, Imaging (ABCD-I) - 7 Days | Sciolla | 2008 | Stroke | Stroke | 1 |
08-046-02 | Age, Blood pressure, Clinical features, Duration of symptoms, Imaging (ABCD-I) - 30 Days | Sciolla | 2008 | Stroke | Stroke | 0 |
05-011-01 | Age, Blood pressure, Clinical features, Duration (ABCD) | Rothwell | 2005 | Stroke | Stroke | 5 |
12-031-01 | Age, Atrial fibrillation, Dysphagia, male Se, stroke Severity, National Institut of Health Stroke Scale (A2DS2) Score | Hoffmann | 2012 | Stroke | Pneumonia | 6 |
12-069-01 | Agarwal 2012 | Agarwal | 2012 | Chronic Heart Failure (CHF) | Mortality | 2 |
12-019-01 | AF Risk Logistic Model Males | El-Chami | 2012 | Coronary Artery Disease (CAD) | Arrhythmia | 1 |
12-019-02 | AF Risk Logistic Model Females | El-Chami | 2012 | Coronary Artery Disease (CAD) | Arrhythmia | 0 |
12-078-01 | Admission Bioclinical (ABC) Score | Degos | 2012 | Stroke | Mortality | 1 |
05-006-01 | Adlam 2005 | Adlam | 2005 | Chronic Heart Failure (CHF) | Mortality | 0 |
99-010-01 | Additive EuroSCORE | Nashef | 1999 | Cardiac Surgery | Mortality | 86 |
14-001-02 | Ad 2014 - 2 Years | Ad | 2014 | Cardiac Surgery | Sinus Rhythm | 0 |
14-001-01 | Ad 2014 - 1 Year | Ad | 2014 | Cardiac Surgery | Sinus Rhythm | 0 |
12-084-01 | Acute Stroke Registry and Analysis of Lausanne (ASTRAL) | Ntaios | 2012 | Stroke | Functional Outcome | 6 |
05-012-01 | Acute Physiology And Chronic Health Evaluation- abdominal aortic aneurysm (APACHE-AAA) Model | Hadjianastassiou | 2005 | Aortic Disease | Mortality | 2 |
91-003-01 | Acute Myocardial Infarction (AMI) Mortality Predictive Instrument | Selker | 1991 | Chest Pain | Mortality | 1 |
13-064-01 | Acute Ischemic Stroke-Associated Pneumonia Score (AIS-APS) | Ji | 2013 | Stroke | Pneumonia | 1 |
05-003-01 | Acute Decompensated Heart Failure National Registry (ADHERE) Score | Fonarow | 2005 | Chronic Heart Failure (CHF) | Mortality | 6 |
13-056-01 | Acute Decompensated Heart Failure (ADHF)/NT-proBNP Risk Score | Scrutinio | 2013 | Chronic Heart Failure (CHF) | Mortality | 1 |
11-050-01 | Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry®Get With The Guidelines (GWTG) Model | Chin | 2011 | Coronary Artery Disease (CAD) | Mortality | 0 |
11-004-01 | Acute Coronary Treatment and Intervention Outcomes Network (ACTION) | Mathews | 2011 | Coronary Artery Disease (CAD) | Hemorrhage | 2 |
12-053-01 | Acute Catheterization and Urgent Intervention Triage StrategyPercutaneous Coronary Intervention (ACUITY-PCI) Risk Score | Palmerini | 2012 | Coronary Artery Disease (CAD) | MACE | 0 |
10-035-01 | Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) | Mehran | 2010 | Coronary Artery Disease (CAD) | Hemorrhage | 4 |
11-060-01 | Action in Diabetes and Vascular disease: preterax and diamicron-MR controlled evaluation (ADVANCE)Risk Engine - Score | Kengne | 2011 | Population Sample | MACCE | 3 |
11-060-02 | Action in Diabetes and Vascular disease: preterax and diamicron-MR controlled evaluation (ADVANCE) Risk Engine - Equation | Kengne | 2011 | Population Sample | MACCE | 0 |
08-007-01 | Abraham 2008 | Abraham | 2008 | Chronic Heart Failure (CHF) | Mortality | 2 |
13-040-01 | Abdelaal 2013 | Abdelaal | 2013 | Coronary Artery Disease (CAD) | Technical Success | 0 |
11-033-01 | Abbas 2011 | Abbas | 2011 | Peripheral Vascular Disease (PVD) | Mortality | 0 |
14-028-01 | Aaronson 2014 | Aaronson | 2014 | Stroke | Sleep Apnea | 0 |
10-049-01 | (P)e(R)i(O)dic (B)reathing during (E)xercise (PROBE) Score | Guazzi | 2010 | Chronic Heart Failure (CHF) | Mortality | 0 |